Hk01的个人主页 - 老虎社区

Hk01

Hk01

暂无个人介绍

IP属地：未知

11关注

10粉丝

0主题

0勋章

2021-12-16

An Apple a day cost about $170.

The 'FAAMG' trade is dead but Apple's appeal stays alive with retail buyers and a $90 billion buyback arsenal, research firm says

2021-12-16

We’ll see in time if it’s really good.

The Next Top Electric Vehicle Stock: Look Out Tesla And Apple

2021-12-16

Really

Foreigners Seen Among Most Affected by Singapore Property Curbs

2021-12-14

Ok

Wall Street ends down; investors eye Omicron and Fed meeting

2021-12-14

Really

5 Stocks To Watch For December 13, 2021

2021-12-13

Nice

Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%

2021-12-10

Wow

Vaccine stocks dropped in morning trading

2021-12-09

Wow

Pear Therapeutics shares soared 75% in premarket trading

2021-12-09

Ok

U.S. Stock Futures Wobble on Omicron Restrictions

2021-12-08

Cool

抱歉，原内容已删除

2021-12-08

Nice

抱歉，原内容已删除

2021-12-05

Wow

抱歉，原内容已删除

2021-11-30

Not cool

'This is not going to be good' -- Moderna CEO on what scientists are telling him about the omicron coronavirus variant

2021-11-30

Great

Apple Stock: Here's Your Chance To Buy

2021-11-30

Cool

JPMorgan Says Omicron Won’t Stop the Global Equities Rally

2021-11-29

Good

Plug Power Stock Looks Promising, But Don’t Get Too Excited Now

2021-11-26

Will this nightmare ever end !!!

Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.

2021-11-25

Ok

抱歉，原内容已删除

2021-11-24

Wow

Musk Passes Tesla Sale Halfway Point With $9.9 Billion Cashed In

2021-11-22

Takeoff

U.S. airlines, airports brace for busy Thanksgiving travel week

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4092737844653660,"uuid":"4092737844653660","gmtCreate":1629940275744,"gmtModify":1630212260093,"name":"Hk01","pinyin":"hk01","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":10,"headSize":11,"tweetSize":99,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":690348613,"gmtCreate":1639642425794,"gmtModify":1639642425968,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"An Apple a day cost about $170. &nbsp;","listText":"An Apple a day cost about $170. &nbsp;","text":"An Apple a day cost about $170.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690348613","repostId":"1168308155","repostType":4,"repost":{"id":"1168308155","pubTimestamp":1639634346,"share":"https://www.laohu8.com/m/news/1168308155?lang=&edition=full","pubTime":"2021-12-16 13:59","market":"us","language":"en","title":"The 'FAAMG' trade is dead but Apple's appeal stays alive with retail buyers and a $90 billion buyback arsenal, research firm says","url":"https://stock-news.laohu8.com/highlight/detail?id=1168308155","media":"Markets Insider","summary":"Apple's following among retail investors and its $90 billion share buyback program is aiding the sto","content":"<ul>\n <li>Apple's following among retail investors and its $90 billion share buyback program is aiding the stock's gains, Vanda Research says.</li>\n <li>One-third of the money retail investors use to buy Nasdaq stocks has been directed into Apple shares.</li>\n <li>Tesla, AMD and Nvidia are also drawing in retail cash, the firm said.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5dd46eb8728000b4bd4342a76800ed71\" tg-width=\"790\" tg-height=\"395\" width=\"100%\" height=\"auto\"><span>A chart of net purchases of tech stocks buy retail investors (Vanda/Bloomberg)</span></p>\n<p>Apple's stock&nbsp;has \"defied all laws of gravity\" this month, remaining on its path toward a $3 trillion market valuation thanks to its power base of retail investors and a multi-billion repurchase program, according to Vanda Research.</p>\n<p>Amateur investors have poured nearly $1.1 billion into Apple shares since the end of November, meaning one-third of all retail money put into constituents of the popular&nbsp;Invesco QQQ Trust&nbsp;ETF is directed to Apple, the firm said in a note Wednesday.</p>\n<p>Meanwhile, the other FAMG stocks excluding APPL have only received 11%, said Vanda. FAMG refers to tech giants&nbsp;Facebook&nbsp;and&nbsp;Amazon&nbsp;and&nbsp;Microsoft&nbsp;and Google's parent&nbsp;Alphabet.</p>\n<p>\"What seems clear is that FAAMG is not a thing anymore, at least not from a retail perspective. The group received very large flows at the start of the pandemic but there has been a changing of the guards since then,\" wrote Vanda analyst Giacomo Pierantoni and senior strategist Ben Onatibia.</p>\n<p>Apple's \"cult following\" by retail buyers combined with the company's $90 billion stock buyback program has helped the price march higher, up by more than 5% in December through Tuesday's session. The stock has gained nearly 36% this year, outpacing the&nbsp;S&amp;P 500's&nbsp;strong 25% advance.</p>\n<p>Tesla&nbsp;and&nbsp;AMD&nbsp;and&nbsp;Nvidia&nbsp;have also caught the attention of retail buyers as they directed about one-third of their money collectively into those Nasdaq stocks since the end of last month. Meanwhile, FAMG stocks (excluding APPL) have only received 11%, said Vanda. FAMG refers to tech giants&nbsp;Facebook&nbsp;and&nbsp;Amazon&nbsp;and&nbsp;Microsoft&nbsp;and Google's parent&nbsp;Alphabet.</p>\n<p>The VandaTrack tool monitors retail-investing activity in 9,000 individual stocks and ETFs in the US.</p>\n<p>\"APPL remains well-loved but the rest of the group has been no match to TSLA, AMD and NVDA's appeal among retail investors. FAAMG is dead, long live the TAAN,\" they said.</p>\n<p>Vanda added this has important implications for investors.</p>\n<p>\"During risk-on rallies, retail demand for TAAN stocks makes them a much higher beta play relative to the FAAMG. But when risk sentiment turns south, stocks with high retail participation usually underperform, unless your treasury desk has $90 billion to spare,\" it said.</p>\n<p>Examples of that dynamic are SPACs and meme stocks, said Vanda. Interest in&nbsp;AMC&nbsp;and&nbsp;GME&nbsp;has waned over time and large sell-offs \"don't find that many enthusiastic buyers,\" it said. \"SPACs were also a vulnerable space given the large inflows that went into EV stocks like&nbsp;Lucid&nbsp;during the Q4 rally.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The 'FAAMG' trade is dead but Apple's appeal stays alive with retail buyers and a $90 billion buyback arsenal, research firm says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe 'FAAMG' trade is dead but Apple's appeal stays alive with retail buyers and a $90 billion buyback arsenal, research firm says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 13:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://markets.businessinsider.com/news/stocks/apple-stock-price-gains-fueled-by-retail-traders-huge-buyback-arsenal-2021-12><strong>Markets Insider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple's following among retail investors and its $90 billion share buyback program is aiding the stock's gains, Vanda Research says.\nOne-third of the money retail investors use to buy Nasdaq stocks ...</p>\n\n<a href=\"https://markets.businessinsider.com/news/stocks/apple-stock-price-gains-fueled-by-retail-traders-huge-buyback-arsenal-2021-12\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","GOOG":"谷歌","GOOGL":"谷歌A","TSLA":"特斯拉","MSFT":"微软","NVDA":"英伟达","AAPL":"苹果"},"source_url":"https://markets.businessinsider.com/news/stocks/apple-stock-price-gains-fueled-by-retail-traders-huge-buyback-arsenal-2021-12","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168308155","content_text":"Apple's following among retail investors and its $90 billion share buyback program is aiding the stock's gains, Vanda Research says.\nOne-third of the money retail investors use to buy Nasdaq stocks has been directed into Apple shares.\nTesla, AMD and Nvidia are also drawing in retail cash, the firm said.\n\nA chart of net purchases of tech stocks buy retail investors (Vanda/Bloomberg)\nApple's stock has \"defied all laws of gravity\" this month, remaining on its path toward a $3 trillion market valuation thanks to its power base of retail investors and a multi-billion repurchase program, according to Vanda Research.\nAmateur investors have poured nearly $1.1 billion into Apple shares since the end of November, meaning one-third of all retail money put into constituents of the popular Invesco QQQ Trust ETF is directed to Apple, the firm said in a note Wednesday.\nMeanwhile, the other FAMG stocks excluding APPL have only received 11%, said Vanda. FAMG refers to tech giants Facebook and Amazon and Microsoft and Google's parent Alphabet.\n\"What seems clear is that FAAMG is not a thing anymore, at least not from a retail perspective. The group received very large flows at the start of the pandemic but there has been a changing of the guards since then,\" wrote Vanda analyst Giacomo Pierantoni and senior strategist Ben Onatibia.\nApple's \"cult following\" by retail buyers combined with the company's $90 billion stock buyback program has helped the price march higher, up by more than 5% in December through Tuesday's session. The stock has gained nearly 36% this year, outpacing the S&P 500's strong 25% advance.\nTesla and AMD and Nvidia have also caught the attention of retail buyers as they directed about one-third of their money collectively into those Nasdaq stocks since the end of last month. Meanwhile, FAMG stocks (excluding APPL) have only received 11%, said Vanda. FAMG refers to tech giants Facebook and Amazon and Microsoft and Google's parent Alphabet.\nThe VandaTrack tool monitors retail-investing activity in 9,000 individual stocks and ETFs in the US.\n\"APPL remains well-loved but the rest of the group has been no match to TSLA, AMD and NVDA's appeal among retail investors. FAAMG is dead, long live the TAAN,\" they said.\nVanda added this has important implications for investors.\n\"During risk-on rallies, retail demand for TAAN stocks makes them a much higher beta play relative to the FAAMG. But when risk sentiment turns south, stocks with high retail participation usually underperform, unless your treasury desk has $90 billion to spare,\" it said.\nExamples of that dynamic are SPACs and meme stocks, said Vanda. Interest in AMC and GME has waned over time and large sell-offs \"don't find that many enthusiastic buyers,\" it said. \"SPACs were also a vulnerable space given the large inflows that went into EV stocks like Lucid during the Q4 rally.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":525,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690341553,"gmtCreate":1639642306522,"gmtModify":1639642321291,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"We’ll see in time if it’s really good.&nbsp;","listText":"We’ll see in time if it’s really good.&nbsp;","text":"We’ll see in time if it’s really good.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690341553","repostId":"1162833574","repostType":4,"repost":{"id":"1162833574","pubTimestamp":1639638037,"share":"https://www.laohu8.com/m/news/1162833574?lang=&edition=full","pubTime":"2021-12-16 15:00","market":"us","language":"en","title":"The Next Top Electric Vehicle Stock: Look Out Tesla And Apple","url":"https://stock-news.laohu8.com/highlight/detail?id=1162833574","media":"Seeking Alpha","summary":"Summary\n\nSemiconductor stocks stand to gain from the global chip shortages. ON Semi, Qualcomm and Mi","content":"<p><b>Summary</b></p>\n<ul>\n <li>Semiconductor stocks stand to gain from the global chip shortages. ON Semi, Qualcomm and Microchip Technology are EV semiconductor stocks to watch.</li>\n <li>The auto sector took a beating during the pandemic but is rebounding. Some EV stocks look attractive given the political environment, rising gas prices, and expansion of charging stations.</li>\n <li>In 2022, US auto sales are expected to increase to $16M from $15M. Top automaker Ford wants all-in on electric and is addressing the chip shortage their way.</li>\n <li>Compared to its EV rivals Tesla and Apple, Ford offers solid fundamentals, a reasonable valuation framework, excellent Quant Factor grades, upward earnings revisions, and incredible stock momentum.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5fe8b143e1df1016169fd2775f2f9d27\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>Bill Pugliano/Getty Images News</span></p>\n<p>Automobiles and Semiconductor Chip Shortage</p>\n<p>Over the last several years, the rapid growth of Electric Vehicles (EV) has been nothing short of astonishing. As Brendan Ahern said in his article,The Unstoppable EV Ecosystem And How To Invest, \"The past two years have seen tremendous excitement in the global electric vehicles (EVs) industry as new companies listed shares, Tesla (TSLA) was added to the S&amp;P 500, global governments stepped up electrification commitments, and electric vehicle sales soared, especially in China and the EU.\" This overview sums up the progress of EVs in the auto sector.</p>\n<p>Our Top Automotive pick, Ford (F), is up 132% YTD and is in an enviable position on fundamentals at this time compared to Tesla, up 37% YTD. And despite Apple's (AAPL)&nbsp;accelerating plans for an autonomous vehicle, which they have deemed their mother of all Ai projects, so far, they are all talk with no viable EV product offering. Apple’s entry into the autonomous vehicle space is a topic of speculation. Notably, there is more than one way to invest in the EV revolution. It comes down to \"what’s inside?\"</p>\n<p>Cars are like the new mainframe computers. A new car can have more than two thousand chips, blowing away a smartphone with perhaps four chips. Semiconductors play a significant role in today's automotive sector, especially EVs, which is why we find their stocks attractive. ON Semi (ON), Qualcomm (QCOM), and Microchip Technology (MCHP) are some of the best suppliers for the automotive sector. Supply chain constraints and Asian factory shutdowns have drastically impacted automotive sales. Despite the supply shortage, there's been high demand, and we've seen the cost of semiconductor shortages balloon above 90%, according to a&nbsp;Bloomberg News Article.</p>\n<p>With a record 21 weeks to fill chip orders,Dan Hearsch, Managing Director of AlixPartners Automotive and Industrial Practice said, \"It certainly feels like the most protracted supply shortage the industry has seen because it's not over.\" Despite the lack of semiconductors, automotive prices continue to climb, reaching records in the U.S. over $42,000 per vehicle, making chip manufacturers like ON Semi, Qualcomm, and Microchip Technology Incorporated Very Bullish buys, especially given their demand in EVs.</p>\n<p><b>ON Semiconductor Corporation</b></p>\n<p>ON Semiconductor is a stock I recently wrote about in an article called&nbsp;Top 5 Tech Stocks For 2022. A Fortune 1000 Company, ON Semi is a semiconductor and leading power management provider that uses signal and custom device technologies for communications, automotive, computing, and other uses. EV advancements allow for increased use of semiconductors in-vehicle platforms' electronics content, improving occupant safety through imaging and sensor function technology; sensor functions by way of algorithms enable vehicles to take immediate action to avoid accidents. This electrification is also used in the powertrain and vehicle auxiliary systems, with semiconductor technology at the forefront.</p>\n<p>The Seeking Alpha News Team recently reported&nbsp;ON Semi as a top pick at Citigroup. Citigroup analyst Christopher Danely said, \"With January's earnings season on the horizon, now is a prime time for investors to buy semiconductor stocks as chip-sector shortages don't appear to be getting better any time soon...Danelynotes that business conditions for the semiconductor industry have not been this strong since 1999 and 2000 and that \"many\" companies are booked solid with orders through 2022.\"</p>\n<p>ON carries a C+ Valuation Grade, remaining attractive relative to its sector by more than 7.29%, at a Forward P/E of 22.43x. Additionally, ON's growth, profitability, and momentum metrics are attractive.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/041f800d3cc6cb924bd6d61c64faf92e\" tg-width=\"640\" tg-height=\"394\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>Momentum is a strong A+ Grade for ON Semiconductor, as they continue to have stellar price returns, with a price-performance return over 10 years exceeding 700%. Diving into ON’s&nbsp;growth grades, the company has a strong year-over-year EBITDA Growth grade of A- at 134.70% above the sector, and EPS FWD Long Term grade of A+, 208% above the sector. As we continue to dive into semiconductors important to vehicle automation, there is another name in the chip industry helping increase the trend towards EVs.</p>\n<p><b>Qualcomm</b></p>\n<p>QCOM gets a significant portion of its revenue from products aimed at the automotive sector. QCOM is already the world's biggest supplier of mobile phone chips, a wireless technology innovator, and 5G driver. The company has announced it will continue to expand into next-generation self-driving vehicles. SA news&nbsp;just reported&nbsp;Qualcomm could rally 25% higher in the next six months, according to Cerity Partners' Jim Lebenthal. Qualcomm, who already works with firms like Microsoft (MSFT) and Meta Platforms (FB), wants to grab hold of the EV market share, which is significantly higher than the phone chip industry, according to Cristiano Amon, QCOM President and CEO. In a&nbsp;November Press Release, Amon said, \"Our announcement with BMW today is the onset of a new era in automotive where two technology leaders have come together to design and develop…the next-generation automobile…we see an incredible number of changes in the industry that are driving things and putting Qualcomm at the intersection of demand for virtually every industry.\"</p>\n<p>When looking at QCOM's Factor Grades below, it's clear why we believe they are on solid footing.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ee2ff7cc1f310c6f8fd1e875afacc02e\" tg-width=\"284\" tg-height=\"223\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>QCOM comes at a reasonable valuation, trading nearly 30% below its sector with a forward P/E of 17.27+; Forward PEG is almost 63% below the sector. The stock has strong growth, excellent profitability metrics, and many analysts increasing their earnings estimates. As fellow&nbsp;Seeking Alpha author Valuentum writes, \"Qualcomm's growth trajectory is supported by its push into the automotive arena and the IoT trend, which are expected to grow its total addressable market opportunity over the next decade.\"</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/14b7d462d95760ddddea06904c48c60a\" tg-width=\"640\" tg-height=\"430\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>In addition to its strong profitability, QCOM is one of the best dividend-paying technology stocks. QCOM has a Dividend Growth Grade of A+. Because the trend and rise in popularity of electric vehicles is not the only way to make money, we are emphasizing another top semiconductor leading the wave of rising EVs, Microchip Technology Incorporated (MCHP).</p>\n<p><b>Microchip Technology Incorporated</b></p>\n<p>Another top EV chip-maker is MCHP, whose chips are used in wireless apps and devices for power management. MCHP’s chips specifically designed for electric vehicles is the artificial intelligence used to centralize computing and navigation and the powertrains and charging systems. Rated Very Bullish, out of 557 of our&nbsp;Top Tech Stocks, MCHP is ranked in the top 10% of this screener and continues to be on an upward trajectory, as evidenced by its B+ Momentum Grade.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/38fa9b58f8f38267e8104688a79b1c77\" tg-width=\"640\" tg-height=\"204\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>Following recent Q2 Earnings results,Jefferies Financial Group, among other analysts, has increased their MCHP price target of $98 to $109, which implies a 22.7% upside. With an EPS of $1.07 that beat by $0.01 and Revenue of $1.65B beating nearly 26% YoY, it’s no wonder there are 21 FY1 Up Revisions in the last 90 days, prompting an A- Revisions Grade.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fc325cd371e06ec406b8e454cf7c4670\" tg-width=\"640\" tg-height=\"183\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>As we look to the EV sector capitalizing on the use of semiconductors and investors wanting to know more about stocks in this space, let us discuss Ford (F), who recently partnered with GlobalFoundries (GFS), a multinational semiconductor manufacturing and design company to address the semiconductor shortage, thus positioning themselves as the next prominent EV manufacturer to rival Tesla and Apple in the space.</p>\n<p><i><b>YTD F, AAPL, TSLA PRICE RETURN COMPARISON</b></i></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f2175c40e8df25d2f22ed2e219327137\" tg-width=\"640\" tg-height=\"230\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p><b>Ford</b></p>\n<p>Ford has been a differentiator since the invention of the automobile. Ford’s partnering with semiconductor company GlobalFoundries clarifies that it wants to lead the industry and evolve by all means necessary, striking deals with companies to source materials and the parts required to avoid supply chain disruptions. \"Semiconductor is going to become the defining line for differentiation in the automotive experience. I believe you're seeing automotive companies want to become what I would call more silicon aware. And that's exactly what Ford is doing in their MOU they signed with G.F. They want to first make sure that they understand the supply-demand dynamics… to make sure they influence the technology road maps for foundries so that the features that we create align with their needs,\"Tom Caulfield GFS CEO, Q3 2021 Earnings Call. So how does Ford compare to its E.V. rivals, Tesla and Apple, in the electric car race?</p>\n<p><b>Ford Valuation vs. Tesla and Apple</b></p>\n<p>Ford is undervalued with an overall valuation grade of C, forward P/E trading -25.82%, and the sector at 14.55X. The forward PEG ratio has an A+ grade, trading nearly 82% below the sector. When we compare Ford, Apple, and Tesla on Valuation, TSLA and AAPL receive an overall F Grade.</p>\n<p>Compared to Tesla and Apple with F Valuation Grades, both look unattractive on a PEG basis (P/E Ratio divided by EPS long-term growth). Tesla PEG of 3.52X is 263.70% above the sector, and Apple PEG of 2.81X, 70.78% above the sector.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/54c31cedfc851a3fb1072546e0b5c879\" tg-width=\"640\" tg-height=\"440\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>Seeking Alpha’s Valuation Grade provides a unique view of how much a company is worth relative to other stocks in the same sector. Thanks to dozens of underlying metrics, the grades provide an instant characterization of the strength or weakness of the metric compared to similar stocks. Ford looks attractive on a 0.17X PEG basis and is not overvalued compared to the sector, with a median PEG of 0.97X.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bbb961e840c6250e27933fd611faefc6\" tg-width=\"640\" tg-height=\"244\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>While a C grade is not ideal, Ford still looks attractive. As a pioneer in its industry, it should fare well in the EV space. According to Aswath Damodaran,Professor of Finance at the Stern School of Business at N.Y. University, the Automotive and Truck sector is sitting pretty, with a current P/E of 164.37 based upon January 2021 data and expected growth of 18.8% over the next five years with a PEG ratio of 8.87.</p>\n<p>Apple's announcement of a fully autonomous vehicle has turned heads, especially given its wide range of technology and persistent delays to the project.Apple Car Project&nbsp;is being led by Ai and machine learning Chief John Giannandrea. \"We're focusing on autonomous systems. It's a core technology that we view as very important. We sort of see it as the mother of all AI projects. It's probably one of the most difficult AI projects actually to work on\" said,Apple CEO Tim Cook. Whereas Tesla and Ford have a leg up with emphasis in the automotive industry, as&nbsp;John Engel emphasizes in his Seeking Alpha article, \"Ultimately, I see little about the automotive sector – EV or otherwise – that would make it a natural fit for Apple. While I suspect the development of the Apple Car over the next few years will act as a positive catalyst for Apple's stock, it will end up being more of a liability than an asset.\" Let's compare each of their growth and profitability grades.</p>\n<p><b>Ford Growth and Profitability vs. Tesla and Apple</b></p>\n<p>With plans to build over 600,000 EV's annually by 2025 and Ford CEO Jim Farley pushing for 40% of its vehicles to be battery powered by 2030, its transition to electric cars is proving to be successful. Led by its fully-electric Mustang Mach-EFord, Ford set a new September record with EV sales surging 92% from the previous year to 9,150. Adding insult to injury, Doug Field,\"One of the top product leaders from Apple, Tesla and Segway,\"left Apple after aiding in the launch of its electric vehicle, poached by Ford as their new Chief Advanced Technology Officer. Online speculation indicates that this move may be the final nail in the Apple EV coffin. While it's all speculation, as we compare the three EV makers, it's clear why we believe Ford will prove the victor and the EV stock to watch.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eec2355246ce651d0fb1df4614fcf9e5\" tg-width=\"640\" tg-height=\"255\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>Ford has delivered a stock price increase of more than 62% over the last five years and an increase of more than 132% YTD, bringing both A- Growth and A+ Profitability Factor Grades. With a Very Bullish rating and continually evolving in the changing landscape of electric vehicles, Ford is set to continue delivering results in the vehicle sector. Ford is built tough and has been resilient despite chip shortages and the effects brought on by the pandemic. Ford continues to introduce new vehicles and will launch an all-electric&nbsp;F-150 Lightning&nbsp;in 2022 that possesses a maximum towing capacity of 10,000 pounds and a range of up to 300 miles. According to the CEO, there's a massive demand for this truck with 200,000 reservations.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/45b7946a5aed4f7f01a00c1ef0635628\" tg-width=\"640\" tg-height=\"254\" width=\"100%\" height=\"auto\"><span>Image Source: 2022 Ford® F-150 Lightning Electric Truck |All Electric and All F-150</span></p>\n<p>The American-made F-150 Lightning and its next-generation full-size electric pickup are developing in high volumes at its new facility in Blue Oval City, Tennessee. The numbers don't lie, and despite a semiconductor shortage, there's no shortage of buyers seeking Ford vehicles. The momentum is sure to continue, especially as Ford manages its partnership with GlobalFoundries and continues to make strides to outpace Tesla and Apple.</p>\n<p>While we continue to see vehicles generated by Ford, we have yet to see the release of an actual Apple EV. Tesla, on the other hand, the pioneer of the electric vehicle, continues to showcase why their cutting-edge battery technology is rated the best car in its class. It's no secret that Tesla continues to build cars for more and more people, making products accessible and affordable while also bridging the gap towards clean transport and renewable energy.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/85b3fbd9b4798b8e89ef154b6eb78098\" tg-width=\"640\" tg-height=\"339\" width=\"100%\" height=\"auto\"><span>Image Source: Model S</span></p>\n<p>We feel Ford's biggest contender in the EV space is Tesla, and&nbsp;Ford also contends that it will be the No. 2 EV producer in two years. Following a Ford EPS of $0.51 beats by $0.24 and 19 FY1 Up Revisions in the last 90 days, it's no wonder Ford is neck-to-neck with its competitors on Profitability with A+ ratings. Ford's continued strength indicates why&nbsp;Jim Farley, Ford CEO during the Q3 Earnings Call, said, \"We're moving aggressively to lead the electric vehicle revolution, substantially expanding our battery production as we speak today in the U.S. In fact, we already announced plans that will give us enough battery production to meet our mid-decade goal of 141 gigawatts, which is enough to build more than 1 million battery electric vehicles a year, and I think we'll need more.\"</p>\n<p><i><b>FORD EARNINGS AND REVISIONS</b></i></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d1077c0c6a7d52a3c5c3a553c5c5ac32\" tg-width=\"640\" tg-height=\"369\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p><b>Ford, Tesla, and Apple Momentum</b></p>\n<p>Each of the stocks, Ford, Tesla, and Apple continue to put their money where they believe there is an upside. Momentum is a successful trading strategy in which investors buy rising stocks and sell as they're retreating, and it is a vital factor for predicting stock price performance for those wanting to hold long term.</p>\n<p>Investor confidence remains high in the EV space, with each stock exhibiting A or better Momentum Grades. Year-to-date, Ford has remained up 57.27% over the previous three months while the sector is down nearly 5%. Tesla is up 30% and Apple more than 17%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/34c9ba651be822d98ff1d10c0ee70b3a\" tg-width=\"640\" tg-height=\"206\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5548abc16267f2b83467c1e652937cdd\" tg-width=\"640\" tg-height=\"202\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f87dd913db38101b4d1f4b255ee4d28c\" tg-width=\"640\" tg-height=\"207\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p><b>Conclusion: Ford</b><b><i>Is</i></b><b>Built Tough and an EV Stock To Watch</b></p>\n<p>Electric Vehicle stocks can make a great return on investment, especially if you can identify those with fair valuations, excellent fundamentals and capitalize on their growth and momentum. In addition, sectors linked to EVs like semiconductors can also be great stock picks. In the current environment, where each of these stock picks offers a good balance of growth and value, it's a great play to diversify your portfolio and ride the EV and semiconductor wave. With the better valuation and continued advancements and momentum, we believe that Ford is the most opportune of the EV stock picks, but it's up to you to decide for yourself.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Next Top Electric Vehicle Stock: Look Out Tesla And Apple</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Next Top Electric Vehicle Stock: Look Out Tesla And Apple\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 15:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4475255-the-next-top-electric-vehicle-stock-look-out-tesla-and-apple><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nSemiconductor stocks stand to gain from the global chip shortages. ON Semi, Qualcomm and Microchip Technology are EV semiconductor stocks to watch.\nThe auto sector took a beating during the ...</p>\n\n<a href=\"https://seekingalpha.com/article/4475255-the-next-top-electric-vehicle-stock-look-out-tesla-and-apple\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","F":"福特汽车","TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/article/4475255-the-next-top-electric-vehicle-stock-look-out-tesla-and-apple","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162833574","content_text":"Summary\n\nSemiconductor stocks stand to gain from the global chip shortages. ON Semi, Qualcomm and Microchip Technology are EV semiconductor stocks to watch.\nThe auto sector took a beating during the pandemic but is rebounding. Some EV stocks look attractive given the political environment, rising gas prices, and expansion of charging stations.\nIn 2022, US auto sales are expected to increase to $16M from $15M. Top automaker Ford wants all-in on electric and is addressing the chip shortage their way.\nCompared to its EV rivals Tesla and Apple, Ford offers solid fundamentals, a reasonable valuation framework, excellent Quant Factor grades, upward earnings revisions, and incredible stock momentum.\n\nBill Pugliano/Getty Images News\nAutomobiles and Semiconductor Chip Shortage\nOver the last several years, the rapid growth of Electric Vehicles (EV) has been nothing short of astonishing. As Brendan Ahern said in his article,The Unstoppable EV Ecosystem And How To Invest, \"The past two years have seen tremendous excitement in the global electric vehicles (EVs) industry as new companies listed shares, Tesla (TSLA) was added to the S&P 500, global governments stepped up electrification commitments, and electric vehicle sales soared, especially in China and the EU.\" This overview sums up the progress of EVs in the auto sector.\nOur Top Automotive pick, Ford (F), is up 132% YTD and is in an enviable position on fundamentals at this time compared to Tesla, up 37% YTD. And despite Apple's (AAPL) accelerating plans for an autonomous vehicle, which they have deemed their mother of all Ai projects, so far, they are all talk with no viable EV product offering. Apple’s entry into the autonomous vehicle space is a topic of speculation. Notably, there is more than one way to invest in the EV revolution. It comes down to \"what’s inside?\"\nCars are like the new mainframe computers. A new car can have more than two thousand chips, blowing away a smartphone with perhaps four chips. Semiconductors play a significant role in today's automotive sector, especially EVs, which is why we find their stocks attractive. ON Semi (ON), Qualcomm (QCOM), and Microchip Technology (MCHP) are some of the best suppliers for the automotive sector. Supply chain constraints and Asian factory shutdowns have drastically impacted automotive sales. Despite the supply shortage, there's been high demand, and we've seen the cost of semiconductor shortages balloon above 90%, according to a Bloomberg News Article.\nWith a record 21 weeks to fill chip orders,Dan Hearsch, Managing Director of AlixPartners Automotive and Industrial Practice said, \"It certainly feels like the most protracted supply shortage the industry has seen because it's not over.\" Despite the lack of semiconductors, automotive prices continue to climb, reaching records in the U.S. over $42,000 per vehicle, making chip manufacturers like ON Semi, Qualcomm, and Microchip Technology Incorporated Very Bullish buys, especially given their demand in EVs.\nON Semiconductor Corporation\nON Semiconductor is a stock I recently wrote about in an article called Top 5 Tech Stocks For 2022. A Fortune 1000 Company, ON Semi is a semiconductor and leading power management provider that uses signal and custom device technologies for communications, automotive, computing, and other uses. EV advancements allow for increased use of semiconductors in-vehicle platforms' electronics content, improving occupant safety through imaging and sensor function technology; sensor functions by way of algorithms enable vehicles to take immediate action to avoid accidents. This electrification is also used in the powertrain and vehicle auxiliary systems, with semiconductor technology at the forefront.\nThe Seeking Alpha News Team recently reported ON Semi as a top pick at Citigroup. Citigroup analyst Christopher Danely said, \"With January's earnings season on the horizon, now is a prime time for investors to buy semiconductor stocks as chip-sector shortages don't appear to be getting better any time soon...Danelynotes that business conditions for the semiconductor industry have not been this strong since 1999 and 2000 and that \"many\" companies are booked solid with orders through 2022.\"\nON carries a C+ Valuation Grade, remaining attractive relative to its sector by more than 7.29%, at a Forward P/E of 22.43x. Additionally, ON's growth, profitability, and momentum metrics are attractive.\nSource: Seeking Alpha Premium\nMomentum is a strong A+ Grade for ON Semiconductor, as they continue to have stellar price returns, with a price-performance return over 10 years exceeding 700%. Diving into ON’s growth grades, the company has a strong year-over-year EBITDA Growth grade of A- at 134.70% above the sector, and EPS FWD Long Term grade of A+, 208% above the sector. As we continue to dive into semiconductors important to vehicle automation, there is another name in the chip industry helping increase the trend towards EVs.\nQualcomm\nQCOM gets a significant portion of its revenue from products aimed at the automotive sector. QCOM is already the world's biggest supplier of mobile phone chips, a wireless technology innovator, and 5G driver. The company has announced it will continue to expand into next-generation self-driving vehicles. SA news just reported Qualcomm could rally 25% higher in the next six months, according to Cerity Partners' Jim Lebenthal. Qualcomm, who already works with firms like Microsoft (MSFT) and Meta Platforms (FB), wants to grab hold of the EV market share, which is significantly higher than the phone chip industry, according to Cristiano Amon, QCOM President and CEO. In a November Press Release, Amon said, \"Our announcement with BMW today is the onset of a new era in automotive where two technology leaders have come together to design and develop…the next-generation automobile…we see an incredible number of changes in the industry that are driving things and putting Qualcomm at the intersection of demand for virtually every industry.\"\nWhen looking at QCOM's Factor Grades below, it's clear why we believe they are on solid footing.\nSource: Seeking Alpha Premium\nQCOM comes at a reasonable valuation, trading nearly 30% below its sector with a forward P/E of 17.27+; Forward PEG is almost 63% below the sector. The stock has strong growth, excellent profitability metrics, and many analysts increasing their earnings estimates. As fellow Seeking Alpha author Valuentum writes, \"Qualcomm's growth trajectory is supported by its push into the automotive arena and the IoT trend, which are expected to grow its total addressable market opportunity over the next decade.\"\nSource: Seeking Alpha Premium\nIn addition to its strong profitability, QCOM is one of the best dividend-paying technology stocks. QCOM has a Dividend Growth Grade of A+. Because the trend and rise in popularity of electric vehicles is not the only way to make money, we are emphasizing another top semiconductor leading the wave of rising EVs, Microchip Technology Incorporated (MCHP).\nMicrochip Technology Incorporated\nAnother top EV chip-maker is MCHP, whose chips are used in wireless apps and devices for power management. MCHP’s chips specifically designed for electric vehicles is the artificial intelligence used to centralize computing and navigation and the powertrains and charging systems. Rated Very Bullish, out of 557 of our Top Tech Stocks, MCHP is ranked in the top 10% of this screener and continues to be on an upward trajectory, as evidenced by its B+ Momentum Grade.\nSource: Seeking Alpha Premium\nFollowing recent Q2 Earnings results,Jefferies Financial Group, among other analysts, has increased their MCHP price target of $98 to $109, which implies a 22.7% upside. With an EPS of $1.07 that beat by $0.01 and Revenue of $1.65B beating nearly 26% YoY, it’s no wonder there are 21 FY1 Up Revisions in the last 90 days, prompting an A- Revisions Grade.\nSource: Seeking Alpha Premium\nAs we look to the EV sector capitalizing on the use of semiconductors and investors wanting to know more about stocks in this space, let us discuss Ford (F), who recently partnered with GlobalFoundries (GFS), a multinational semiconductor manufacturing and design company to address the semiconductor shortage, thus positioning themselves as the next prominent EV manufacturer to rival Tesla and Apple in the space.\nYTD F, AAPL, TSLA PRICE RETURN COMPARISON\nSource: Seeking Alpha Premium\nFord\nFord has been a differentiator since the invention of the automobile. Ford’s partnering with semiconductor company GlobalFoundries clarifies that it wants to lead the industry and evolve by all means necessary, striking deals with companies to source materials and the parts required to avoid supply chain disruptions. \"Semiconductor is going to become the defining line for differentiation in the automotive experience. I believe you're seeing automotive companies want to become what I would call more silicon aware. And that's exactly what Ford is doing in their MOU they signed with G.F. They want to first make sure that they understand the supply-demand dynamics… to make sure they influence the technology road maps for foundries so that the features that we create align with their needs,\"Tom Caulfield GFS CEO, Q3 2021 Earnings Call. So how does Ford compare to its E.V. rivals, Tesla and Apple, in the electric car race?\nFord Valuation vs. Tesla and Apple\nFord is undervalued with an overall valuation grade of C, forward P/E trading -25.82%, and the sector at 14.55X. The forward PEG ratio has an A+ grade, trading nearly 82% below the sector. When we compare Ford, Apple, and Tesla on Valuation, TSLA and AAPL receive an overall F Grade.\nCompared to Tesla and Apple with F Valuation Grades, both look unattractive on a PEG basis (P/E Ratio divided by EPS long-term growth). Tesla PEG of 3.52X is 263.70% above the sector, and Apple PEG of 2.81X, 70.78% above the sector.\nSource: Seeking Alpha Premium\nSeeking Alpha’s Valuation Grade provides a unique view of how much a company is worth relative to other stocks in the same sector. Thanks to dozens of underlying metrics, the grades provide an instant characterization of the strength or weakness of the metric compared to similar stocks. Ford looks attractive on a 0.17X PEG basis and is not overvalued compared to the sector, with a median PEG of 0.97X.\nSource: Seeking Alpha Premium\nWhile a C grade is not ideal, Ford still looks attractive. As a pioneer in its industry, it should fare well in the EV space. According to Aswath Damodaran,Professor of Finance at the Stern School of Business at N.Y. University, the Automotive and Truck sector is sitting pretty, with a current P/E of 164.37 based upon January 2021 data and expected growth of 18.8% over the next five years with a PEG ratio of 8.87.\nApple's announcement of a fully autonomous vehicle has turned heads, especially given its wide range of technology and persistent delays to the project.Apple Car Project is being led by Ai and machine learning Chief John Giannandrea. \"We're focusing on autonomous systems. It's a core technology that we view as very important. We sort of see it as the mother of all AI projects. It's probably one of the most difficult AI projects actually to work on\" said,Apple CEO Tim Cook. Whereas Tesla and Ford have a leg up with emphasis in the automotive industry, as John Engel emphasizes in his Seeking Alpha article, \"Ultimately, I see little about the automotive sector – EV or otherwise – that would make it a natural fit for Apple. While I suspect the development of the Apple Car over the next few years will act as a positive catalyst for Apple's stock, it will end up being more of a liability than an asset.\" Let's compare each of their growth and profitability grades.\nFord Growth and Profitability vs. Tesla and Apple\nWith plans to build over 600,000 EV's annually by 2025 and Ford CEO Jim Farley pushing for 40% of its vehicles to be battery powered by 2030, its transition to electric cars is proving to be successful. Led by its fully-electric Mustang Mach-EFord, Ford set a new September record with EV sales surging 92% from the previous year to 9,150. Adding insult to injury, Doug Field,\"One of the top product leaders from Apple, Tesla and Segway,\"left Apple after aiding in the launch of its electric vehicle, poached by Ford as their new Chief Advanced Technology Officer. Online speculation indicates that this move may be the final nail in the Apple EV coffin. While it's all speculation, as we compare the three EV makers, it's clear why we believe Ford will prove the victor and the EV stock to watch.\nSource: Seeking Alpha Premium\nFord has delivered a stock price increase of more than 62% over the last five years and an increase of more than 132% YTD, bringing both A- Growth and A+ Profitability Factor Grades. With a Very Bullish rating and continually evolving in the changing landscape of electric vehicles, Ford is set to continue delivering results in the vehicle sector. Ford is built tough and has been resilient despite chip shortages and the effects brought on by the pandemic. Ford continues to introduce new vehicles and will launch an all-electric F-150 Lightning in 2022 that possesses a maximum towing capacity of 10,000 pounds and a range of up to 300 miles. According to the CEO, there's a massive demand for this truck with 200,000 reservations.\nImage Source: 2022 Ford® F-150 Lightning Electric Truck |All Electric and All F-150\nThe American-made F-150 Lightning and its next-generation full-size electric pickup are developing in high volumes at its new facility in Blue Oval City, Tennessee. The numbers don't lie, and despite a semiconductor shortage, there's no shortage of buyers seeking Ford vehicles. The momentum is sure to continue, especially as Ford manages its partnership with GlobalFoundries and continues to make strides to outpace Tesla and Apple.\nWhile we continue to see vehicles generated by Ford, we have yet to see the release of an actual Apple EV. Tesla, on the other hand, the pioneer of the electric vehicle, continues to showcase why their cutting-edge battery technology is rated the best car in its class. It's no secret that Tesla continues to build cars for more and more people, making products accessible and affordable while also bridging the gap towards clean transport and renewable energy.\nImage Source: Model S\nWe feel Ford's biggest contender in the EV space is Tesla, and Ford also contends that it will be the No. 2 EV producer in two years. Following a Ford EPS of $0.51 beats by $0.24 and 19 FY1 Up Revisions in the last 90 days, it's no wonder Ford is neck-to-neck with its competitors on Profitability with A+ ratings. Ford's continued strength indicates why Jim Farley, Ford CEO during the Q3 Earnings Call, said, \"We're moving aggressively to lead the electric vehicle revolution, substantially expanding our battery production as we speak today in the U.S. In fact, we already announced plans that will give us enough battery production to meet our mid-decade goal of 141 gigawatts, which is enough to build more than 1 million battery electric vehicles a year, and I think we'll need more.\"\nFORD EARNINGS AND REVISIONS\nSource: Seeking Alpha Premium\nFord, Tesla, and Apple Momentum\nEach of the stocks, Ford, Tesla, and Apple continue to put their money where they believe there is an upside. Momentum is a successful trading strategy in which investors buy rising stocks and sell as they're retreating, and it is a vital factor for predicting stock price performance for those wanting to hold long term.\nInvestor confidence remains high in the EV space, with each stock exhibiting A or better Momentum Grades. Year-to-date, Ford has remained up 57.27% over the previous three months while the sector is down nearly 5%. Tesla is up 30% and Apple more than 17%.\nSource: Seeking Alpha Premium\nSource: Seeking Alpha Premium\nSource: Seeking Alpha Premium\nConclusion: FordIsBuilt Tough and an EV Stock To Watch\nElectric Vehicle stocks can make a great return on investment, especially if you can identify those with fair valuations, excellent fundamentals and capitalize on their growth and momentum. In addition, sectors linked to EVs like semiconductors can also be great stock picks. In the current environment, where each of these stock picks offers a good balance of growth and value, it's a great play to diversify your portfolio and ride the EV and semiconductor wave. With the better valuation and continued advancements and momentum, we believe that Ford is the most opportune of the EV stock picks, but it's up to you to decide for yourself.","news_type":1},"isVote":1,"tweetType":1,"viewCount":661,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690343729,"gmtCreate":1639642161719,"gmtModify":1639642205735,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Really","listText":"Really","text":"Really","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690343729","repostId":"1127770254","repostType":4,"repost":{"id":"1127770254","pubTimestamp":1639641940,"share":"https://www.laohu8.com/m/news/1127770254?lang=&edition=full","pubTime":"2021-12-16 16:05","market":"sg","language":"en","title":"Foreigners Seen Among Most Affected by Singapore Property Curbs","url":"https://stock-news.laohu8.com/highlight/detail?id=1127770254","media":"Bloomberg","summary":"New cooling measures introduced by Singapore on Thursday to prevent home buyers from over-leveraging","content":"<p>New&nbsp;cooling measures&nbsp;introduced by Singapore on Thursday to prevent home buyers from over-leveraging may slow purchases by permanent residents and expatriates the most, according to a statement released by industry watcher OrangeTee &amp; Tie.</p>\n<p>The number of condominiums purchased by Singapore permanent residents has increased by 55.3% this year, the most among all categories, with foreign purchases up by 45%.</p>\n<p>As vaccinated travel lane arrangements and borders reopen further, more permanent residents and foreigners are expected to return and create higher demand. The increase in stamp duties for second-home buyers and foreigners purchasing private property is expected to slow demand from this segment, said Christine Sun, senior vice president of research and analytics at the company.</p>\n<p>While investors, rather than owner-occupiers, are seen as taking the biggest hit from the measures, the industry watcher has revised its price projections for overall Singapore private property down from 6% to 9% growth in 2022 to 0% to 3%.</p>\n<p>Number of non-landed homes sold by residential status</p>\n<table>\n <tbody>\n  <tr></tr>\n  <tr>\n   <th>NATIONALITY BY RESIDENTIAL STATUS</th>\n   <th>2018</th>\n   <th>2019</th>\n   <th>2020</th>\n   <th>2021*</th>\n   <th>2021 VS 2020</th>\n  </tr>\n  <tr>\n   <td>Foreigner (NPR)</td>\n   <td>1216</td>\n   <td>1000</td>\n   <td>737</td>\n   <td>1069</td>\n   <td>45.0%</td>\n  </tr>\n  <tr>\n   <td>Singapore Permanent Residents (PR)</td>\n   <td>3234</td>\n   <td>2598</td>\n   <td>2818</td>\n   <td>4375</td>\n   <td>55.3%</td>\n  </tr>\n  <tr>\n   <td>Singaporean</td>\n   <td>14805</td>\n   <td>13008</td>\n   <td>14677</td>\n   <td>22113</td>\n   <td>50.7%</td>\n  </tr>\n  <tr>\n   <td>Company</td>\n   <td>88</td>\n   <td>35</td>\n   <td>59</td>\n   <td>46</td>\n   <td>-22.0%</td>\n  </tr>\n  <tr>\n   <td>N.A</td>\n   <td>0</td>\n   <td>2</td>\n   <td>5</td>\n   <td>1</td>\n   <td>-80.0%</td>\n  </tr>\n  <tr>\n   <td>Total</td>\n   <td>19343</td>\n   <td>16643</td>\n   <td>18296</td>\n   <td>27604</td>\n   <td>50.9%</td>\n  </tr>\n </tbody>\n</table>\n<p>Source: Urban Redevelopment Authority, OrangeTee &amp; Tie Research &amp; Analytics</p>\n<p>Note: 2021 data for condominium sales doesn’t include all of December.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Foreigners Seen Among Most Affected by Singapore Property Curbs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForeigners Seen Among Most Affected by Singapore Property Curbs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 16:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-16/foreigners-seen-among-most-affected-by-singapore-property-curbs><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New cooling measures introduced by Singapore on Thursday to prevent home buyers from over-leveraging may slow purchases by permanent residents and expatriates the most, according to a statement ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-16/foreigners-seen-among-most-affected-by-singapore-property-curbs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-16/foreigners-seen-among-most-affected-by-singapore-property-curbs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127770254","content_text":"New cooling measures introduced by Singapore on Thursday to prevent home buyers from over-leveraging may slow purchases by permanent residents and expatriates the most, according to a statement released by industry watcher OrangeTee & Tie.\nThe number of condominiums purchased by Singapore permanent residents has increased by 55.3% this year, the most among all categories, with foreign purchases up by 45%.\nAs vaccinated travel lane arrangements and borders reopen further, more permanent residents and foreigners are expected to return and create higher demand. The increase in stamp duties for second-home buyers and foreigners purchasing private property is expected to slow demand from this segment, said Christine Sun, senior vice president of research and analytics at the company.\nWhile investors, rather than owner-occupiers, are seen as taking the biggest hit from the measures, the industry watcher has revised its price projections for overall Singapore private property down from 6% to 9% growth in 2022 to 0% to 3%.\nNumber of non-landed homes sold by residential status\n\n\n\n\nNATIONALITY BY RESIDENTIAL STATUS\n2018\n2019\n2020\n2021*\n2021 VS 2020\n\n\nForeigner (NPR)\n1216\n1000\n737\n1069\n45.0%\n\n\nSingapore Permanent Residents (PR)\n3234\n2598\n2818\n4375\n55.3%\n\n\nSingaporean\n14805\n13008\n14677\n22113\n50.7%\n\n\nCompany\n88\n35\n59\n46\n-22.0%\n\n\nN.A\n0\n2\n5\n1\n-80.0%\n\n\nTotal\n19343\n16643\n18296\n27604\n50.9%\n\n\n\nSource: Urban Redevelopment Authority, OrangeTee & Tie Research & Analytics\nNote: 2021 data for condominium sales doesn’t include all of December.","news_type":1},"isVote":1,"tweetType":1,"viewCount":677,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604421493,"gmtCreate":1639440410708,"gmtModify":1639440410893,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604421493","repostId":"2191984334","repostType":4,"repost":{"id":"2191984334","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639435732,"share":"https://www.laohu8.com/m/news/2191984334?lang=&edition=full","pubTime":"2021-12-14 06:48","market":"us","language":"en","title":"Wall Street ends down; investors eye Omicron and Fed meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2191984334","media":"Reuters","summary":"* Pfizer to buy Arena Pharma, shares of both companies rise\n* Meme stocks GameStop, AMC slump to mul","content":"<p>* Pfizer to buy Arena Pharma, shares of both companies rise</p>\n<p>*&nbsp;Meme stocks GameStop, AMC slump to multi-month lows</p>\n<p>* Consumer discretionary, energy lead declines</p>\n<p>Dec 13 (Reuters) - Wall Street ended lower on Monday, with shares of Carnival Corp and several airlines tumbling as investors worried about the Omicron coronavirus variant ahead of a Federal Reserve meeting later this week.</p>\n<p>Travel-related stocks fell, with the fast-spreading variant accounting for around 40% of COVID-19 infections in London and at least one death in the United Kingdom.</p>\n<p>Norwegian Cruise Line Holdings, Carnival Corp&nbsp;and Royal Caribbean Cruises&nbsp;all slumped more than 4%, while the S&amp;P 1500 airlines index&nbsp;shed about 3%.</p>\n<p>\"It's transportation, restaurants, all the things that if it got bad enough that we started putting new restrictions on people, it would not be good for them,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They have all been bid over the past several months by the idea that we were going to get back to business as usual.\"</p>\n<p>Most of the 11 major S&amp;P 500 sector indexes fell, with only defensive sectors, including consumer staples, utilities&nbsp;and real estate&nbsp;gaining.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 0.89% to end at 35,650.95 points, while the S&amp;P 500&nbsp;lost 0.91% to 4,668.97.</p>\n<p>The Nasdaq Composite&nbsp;dropped 1.39% to 15,413.28.</p>\n<p>Following Monday's dip, the S&amp;P 500 remains up about 24% year to date.</p>\n<p>Apple Inc&nbsp;dipped 2.1%, even after J.P. Morgan raised its price target on the iPhone maker to the highest on Wall Street. The company is close to becoming the first in the world to hit $3 trillion in market value.</p>\n<p>Investors expect an increasingly hawkish tone out of the Federal Reserve's two-day meeting that wraps up on Wednesday. The U.S. central bank is expected to signal a faster wind-down of asset purchases, which could also usher closer a start to interest rate hikes.</p>\n<p>\"Everyone is focused on the Fed this week and what guidance we get in terms of bond purchases and interest rates. There's an expectation that there will be an acceleration of tapering, and there's a little anxiety leading up to that,\" said Ryan Jacob, chief portfolio manager at Jacob Internet Fund.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p>Positive updates about vaccines and antibody cocktails to combat the new COVID-19 variant, along with a recent reading on inflation that was in line with consensus, pushed the S&amp;P 500&nbsp;index to a record closing high on Friday.</p>\n<p>Pfizer Inc&nbsp;rose 4.6% after it agreed to acquire Arena Pharmaceuticals&nbsp;in a $6.7 billion all-cash deal. Arena's shares surged 80%.</p>\n<p>Shares of Gamestop&nbsp;and AMC Entertainment&nbsp;tumbled to multi-month lows on Monday as some investors appeared to sour on the names that had produced eye-watering gains earlier in the year.</p>\n<p>Video game retailer GameStop tumbled 13.9% at $136.88, briefly touching its lowest level since April, while movie theater operator AMC slumped 15.3% to $23.24, a level last seen in May.</p>\n<p>Volume on U.S. exchanges was 10.4 billion shares, compared with the 11.4 billion average over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.30-to-1 ratio; on Nasdaq, a 2.53-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 33 new highs and 302 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down; investors eye Omicron and Fed meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down; investors eye Omicron and Fed meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-14 06:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Pfizer to buy Arena Pharma, shares of both companies rise</p>\n<p>*&nbsp;Meme stocks GameStop, AMC slump to multi-month lows</p>\n<p>* Consumer discretionary, energy lead declines</p>\n<p>Dec 13 (Reuters) - Wall Street ended lower on Monday, with shares of Carnival Corp and several airlines tumbling as investors worried about the Omicron coronavirus variant ahead of a Federal Reserve meeting later this week.</p>\n<p>Travel-related stocks fell, with the fast-spreading variant accounting for around 40% of COVID-19 infections in London and at least one death in the United Kingdom.</p>\n<p>Norwegian Cruise Line Holdings, Carnival Corp&nbsp;and Royal Caribbean Cruises&nbsp;all slumped more than 4%, while the S&amp;P 1500 airlines index&nbsp;shed about 3%.</p>\n<p>\"It's transportation, restaurants, all the things that if it got bad enough that we started putting new restrictions on people, it would not be good for them,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They have all been bid over the past several months by the idea that we were going to get back to business as usual.\"</p>\n<p>Most of the 11 major S&amp;P 500 sector indexes fell, with only defensive sectors, including consumer staples, utilities&nbsp;and real estate&nbsp;gaining.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 0.89% to end at 35,650.95 points, while the S&amp;P 500&nbsp;lost 0.91% to 4,668.97.</p>\n<p>The Nasdaq Composite&nbsp;dropped 1.39% to 15,413.28.</p>\n<p>Following Monday's dip, the S&amp;P 500 remains up about 24% year to date.</p>\n<p>Apple Inc&nbsp;dipped 2.1%, even after J.P. Morgan raised its price target on the iPhone maker to the highest on Wall Street. The company is close to becoming the first in the world to hit $3 trillion in market value.</p>\n<p>Investors expect an increasingly hawkish tone out of the Federal Reserve's two-day meeting that wraps up on Wednesday. The U.S. central bank is expected to signal a faster wind-down of asset purchases, which could also usher closer a start to interest rate hikes.</p>\n<p>\"Everyone is focused on the Fed this week and what guidance we get in terms of bond purchases and interest rates. There's an expectation that there will be an acceleration of tapering, and there's a little anxiety leading up to that,\" said Ryan Jacob, chief portfolio manager at Jacob Internet Fund.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p>Positive updates about vaccines and antibody cocktails to combat the new COVID-19 variant, along with a recent reading on inflation that was in line with consensus, pushed the S&amp;P 500&nbsp;index to a record closing high on Friday.</p>\n<p>Pfizer Inc&nbsp;rose 4.6% after it agreed to acquire Arena Pharmaceuticals&nbsp;in a $6.7 billion all-cash deal. Arena's shares surged 80%.</p>\n<p>Shares of Gamestop&nbsp;and AMC Entertainment&nbsp;tumbled to multi-month lows on Monday as some investors appeared to sour on the names that had produced eye-watering gains earlier in the year.</p>\n<p>Video game retailer GameStop tumbled 13.9% at $136.88, briefly touching its lowest level since April, while movie theater operator AMC slumped 15.3% to $23.24, a level last seen in May.</p>\n<p>Volume on U.S. exchanges was 10.4 billion shares, compared with the 11.4 billion average over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.30-to-1 ratio; on Nasdaq, a 2.53-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 33 new highs and 302 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CCL":"嘉年华邮轮","SQQQ":"纳指三倍做空ETF","BK4517":"邮轮概念","QID":"纳指两倍做空ETF","ARNA":"阿里那","BK4142":"酒店、度假村与豪华游轮","DDM":"道指两倍做多ETF","PSQ":"纳指反向ETF","UDOW":"道指三倍做多ETF-ProShares","DOG":"道指反向ETF","PFE":"辉瑞","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","DXD":"道指两倍做空ETF","BK4139":"生物科技","TQQQ":"纳指三倍做多ETF","NCLH":"挪威邮轮","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","BK4566":"资本集团","SDOW":"道指三倍做空ETF-ProShares","BK4568":"美国抗疫概念","RCL":"皇家加勒比邮轮","DJX":"1/100道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191984334","content_text":"* Pfizer to buy Arena Pharma, shares of both companies rise\n* Meme stocks GameStop, AMC slump to multi-month lows\n* Consumer discretionary, energy lead declines\nDec 13 (Reuters) - Wall Street ended lower on Monday, with shares of Carnival Corp and several airlines tumbling as investors worried about the Omicron coronavirus variant ahead of a Federal Reserve meeting later this week.\nTravel-related stocks fell, with the fast-spreading variant accounting for around 40% of COVID-19 infections in London and at least one death in the United Kingdom.\nNorwegian Cruise Line Holdings, Carnival Corp and Royal Caribbean Cruises all slumped more than 4%, while the S&P 1500 airlines index shed about 3%.\n\"It's transportation, restaurants, all the things that if it got bad enough that we started putting new restrictions on people, it would not be good for them,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They have all been bid over the past several months by the idea that we were going to get back to business as usual.\"\nMost of the 11 major S&P 500 sector indexes fell, with only defensive sectors, including consumer staples, utilities and real estate gaining.\nThe Dow Jones Industrial Average fell 0.89% to end at 35,650.95 points, while the S&P 500 lost 0.91% to 4,668.97.\nThe Nasdaq Composite dropped 1.39% to 15,413.28.\nFollowing Monday's dip, the S&P 500 remains up about 24% year to date.\nApple Inc dipped 2.1%, even after J.P. Morgan raised its price target on the iPhone maker to the highest on Wall Street. The company is close to becoming the first in the world to hit $3 trillion in market value.\nInvestors expect an increasingly hawkish tone out of the Federal Reserve's two-day meeting that wraps up on Wednesday. The U.S. central bank is expected to signal a faster wind-down of asset purchases, which could also usher closer a start to interest rate hikes.\n\"Everyone is focused on the Fed this week and what guidance we get in terms of bond purchases and interest rates. There's an expectation that there will be an acceleration of tapering, and there's a little anxiety leading up to that,\" said Ryan Jacob, chief portfolio manager at Jacob Internet Fund.\nA Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.\nPositive updates about vaccines and antibody cocktails to combat the new COVID-19 variant, along with a recent reading on inflation that was in line with consensus, pushed the S&P 500 index to a record closing high on Friday.\nPfizer Inc rose 4.6% after it agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal. Arena's shares surged 80%.\nShares of Gamestop and AMC Entertainment tumbled to multi-month lows on Monday as some investors appeared to sour on the names that had produced eye-watering gains earlier in the year.\nVideo game retailer GameStop tumbled 13.9% at $136.88, briefly touching its lowest level since April, while movie theater operator AMC slumped 15.3% to $23.24, a level last seen in May.\nVolume on U.S. exchanges was 10.4 billion shares, compared with the 11.4 billion average over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.30-to-1 ratio; on Nasdaq, a 2.53-to-1 ratio favored decliners.\nThe S&P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 33 new highs and 302 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":705,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604421241,"gmtCreate":1639440365158,"gmtModify":1639440365342,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Really&nbsp;","listText":"Really&nbsp;","text":"Really","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604421241","repostId":"1165575464","repostType":4,"repost":{"id":"1165575464","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639387544,"share":"https://www.laohu8.com/m/news/1165575464?lang=&edition=full","pubTime":"2021-12-13 17:25","market":"us","language":"en","title":"5 Stocks To Watch For December 13, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1165575464","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Qudian Inc. to repor","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects&nbsp;<b>Qudian Inc.</b>&nbsp;to report quarterly earnings at $0.34 per share on revenue of $117.22 million before the opening bell. Qudian shares rose 2.9% to close at $1.40 on Friday.</li>\n <li><b>SIFCO Industries, Inc.</b>&nbsp;reported a net loss of $0.43 per share for the fourth quarter of fiscal 2021, versus year-ago net income of $0.86 per share. Its net sales dropped 16.3% to $24.3 million. SIFCO Industries shares fell 0.5% to close at $8.76 on Friday.</li>\n <li>Analysts are expecting&nbsp;<b>J.Jill, Inc.</b>&nbsp;to have earned $0.34 per share on revenue of $117.22 million for the latest quarter. J.Jill will release earnings after the markets close. Johnson Outdoors shares slipped 0.8% to close at $15.39 on Friday.</li>\n</ul>\n<ul>\n <li><b>Proto Labs Inc</b>&nbsp;announced a $50 million increase to its stock buyback plan. The recent authorization raises the repurchase program to $150 million. Proto Labs shares gained 0.9% to $50.02 in the after-hours trading session.</li>\n <li>Analysts expect&nbsp;<b>Zedge, Inc.</b>&nbsp;to post quarterly earnings at $0.12 per share on revenue of $5.26 million after the closing bell. Zedge shares dropped 0.9% to $9.16 in after-hours trading.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For December 13, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For December 13, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-13 17:25</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects&nbsp;<b>Qudian Inc.</b>&nbsp;to report quarterly earnings at $0.34 per share on revenue of $117.22 million before the opening bell. Qudian shares rose 2.9% to close at $1.40 on Friday.</li>\n <li><b>SIFCO Industries, Inc.</b>&nbsp;reported a net loss of $0.43 per share for the fourth quarter of fiscal 2021, versus year-ago net income of $0.86 per share. Its net sales dropped 16.3% to $24.3 million. SIFCO Industries shares fell 0.5% to close at $8.76 on Friday.</li>\n <li>Analysts are expecting&nbsp;<b>J.Jill, Inc.</b>&nbsp;to have earned $0.34 per share on revenue of $117.22 million for the latest quarter. J.Jill will release earnings after the markets close. Johnson Outdoors shares slipped 0.8% to close at $15.39 on Friday.</li>\n</ul>\n<ul>\n <li><b>Proto Labs Inc</b>&nbsp;announced a $50 million increase to its stock buyback plan. The recent authorization raises the repurchase program to $150 million. Proto Labs shares gained 0.9% to $50.02 in the after-hours trading session.</li>\n <li>Analysts expect&nbsp;<b>Zedge, Inc.</b>&nbsp;to post quarterly earnings at $0.12 per share on revenue of $5.26 million after the closing bell. Zedge shares dropped 0.9% to $9.16 in after-hours trading.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QD":"趣店","JILL":"J.Jill Inc.","ZDGE":"Zedge, Inc. Class B","SIF":"SIFCO Industries Inc","PRLB":"Proto Labs Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165575464","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Qudian Inc. to report quarterly earnings at $0.34 per share on revenue of $117.22 million before the opening bell. Qudian shares rose 2.9% to close at $1.40 on Friday.\nSIFCO Industries, Inc. reported a net loss of $0.43 per share for the fourth quarter of fiscal 2021, versus year-ago net income of $0.86 per share. Its net sales dropped 16.3% to $24.3 million. SIFCO Industries shares fell 0.5% to close at $8.76 on Friday.\nAnalysts are expecting J.Jill, Inc. to have earned $0.34 per share on revenue of $117.22 million for the latest quarter. J.Jill will release earnings after the markets close. Johnson Outdoors shares slipped 0.8% to close at $15.39 on Friday.\n\n\nProto Labs Inc announced a $50 million increase to its stock buyback plan. The recent authorization raises the repurchase program to $150 million. Proto Labs shares gained 0.9% to $50.02 in the after-hours trading session.\nAnalysts expect Zedge, Inc. to post quarterly earnings at $0.12 per share on revenue of $5.26 million after the closing bell. Zedge shares dropped 0.9% to $9.16 in after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":971,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604279292,"gmtCreate":1639407389820,"gmtModify":1639407390372,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604279292","repostId":"1133455327","repostType":4,"repost":{"id":"1133455327","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406792,"share":"https://www.laohu8.com/m/news/1133455327?lang=&edition=full","pubTime":"2021-12-13 22:46","market":"us","language":"en","title":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133455327","media":"Tiger Newspress","summary":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping ove","content":"<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133455327","content_text":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.\nA new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.","news_type":1},"isVote":1,"tweetType":1,"viewCount":571,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605690209,"gmtCreate":1639149465713,"gmtModify":1639149465835,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow&nbsp;","listText":"Wow&nbsp;","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605690209","repostId":"1148141788","repostType":4,"repost":{"id":"1148141788","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639147224,"share":"https://www.laohu8.com/m/news/1148141788?lang=&edition=full","pubTime":"2021-12-10 22:40","market":"us","language":"en","title":"Vaccine stocks dropped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1148141788","media":"Tiger Newspress","summary":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","content":"<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech&nbsp;and&nbsp;Novavax&nbsp;fell&nbsp;between 2% and 11%.</p>\n<p><img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks dropped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks dropped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech&nbsp;and&nbsp;Novavax&nbsp;fell&nbsp;between 2% and 11%.</p>\n<p><img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148141788","content_text":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":472,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602415427,"gmtCreate":1639056708676,"gmtModify":1639057201069,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602415427","repostId":"1117677376","repostType":4,"repost":{"id":"1117677376","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639041481,"share":"https://www.laohu8.com/m/news/1117677376?lang=&edition=full","pubTime":"2021-12-09 17:18","market":"us","language":"en","title":"Pear Therapeutics shares soared 75% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1117677376","media":"Tiger Newspress","summary":"Pear Therapeutics shares soared 75% in premarket trading.\n\nPrescription digital therapeutics company","content":"<p>Pear Therapeutics shares soared 75% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/1aa8562d3d7942fc80a42167c422600c\" tg-width=\"851\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Prescription digital therapeutics company&nbsp;Pear Therapeutics&nbsp;began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company&nbsp;Thimble Point Acquisition Corp.&nbsp;last week.</p>\n<p>The business combination brought in about $175 million, which the company said will be used to capitalize its digital therapeutic products. It's trading under the ticker symbol PEAR.</p>\n<p>\"My Pearmates and I are proud to continue our leadership in the creation of prescription digital therapeutics,\"&nbsp;Pear President and CEO Dr. Corey McCann&nbsp;said in a statement. \"As a public company, we aim to accelerate our vision to increase access to PDTs [prescription digital therapeutics] by further commercializing our three FDA-authorized PDTs, expanding public and private payer adoption, and advancing our pipeline of PDTs. Thanks to all of our investors for supporting our successful transition.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pear Therapeutics shares soared 75% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPear Therapeutics shares soared 75% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-09 17:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pear Therapeutics shares soared 75% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/1aa8562d3d7942fc80a42167c422600c\" tg-width=\"851\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Prescription digital therapeutics company&nbsp;Pear Therapeutics&nbsp;began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company&nbsp;Thimble Point Acquisition Corp.&nbsp;last week.</p>\n<p>The business combination brought in about $175 million, which the company said will be used to capitalize its digital therapeutic products. It's trading under the ticker symbol PEAR.</p>\n<p>\"My Pearmates and I are proud to continue our leadership in the creation of prescription digital therapeutics,\"&nbsp;Pear President and CEO Dr. Corey McCann&nbsp;said in a statement. \"As a public company, we aim to accelerate our vision to increase access to PDTs [prescription digital therapeutics] by further commercializing our three FDA-authorized PDTs, expanding public and private payer adoption, and advancing our pipeline of PDTs. Thanks to all of our investors for supporting our successful transition.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PEAR":"Pear Therapeutics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117677376","content_text":"Pear Therapeutics shares soared 75% in premarket trading.\n\nPrescription digital therapeutics company Pear Therapeutics began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company Thimble Point Acquisition Corp. last week.\nThe business combination brought in about $175 million, which the company said will be used to capitalize its digital therapeutic products. It's trading under the ticker symbol PEAR.\n\"My Pearmates and I are proud to continue our leadership in the creation of prescription digital therapeutics,\" Pear President and CEO Dr. Corey McCann said in a statement. \"As a public company, we aim to accelerate our vision to increase access to PDTs [prescription digital therapeutics] by further commercializing our three FDA-authorized PDTs, expanding public and private payer adoption, and advancing our pipeline of PDTs. Thanks to all of our investors for supporting our successful transition.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":698,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602415115,"gmtCreate":1639056629754,"gmtModify":1639057198835,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602415115","repostId":"1192937541","repostType":4,"repost":{"id":"1192937541","pubTimestamp":1639045976,"share":"https://www.laohu8.com/m/news/1192937541?lang=&edition=full","pubTime":"2021-12-09 18:32","market":"us","language":"en","title":"U.S. Stock Futures Wobble on Omicron Restrictions","url":"https://stock-news.laohu8.com/highlight/detail?id=1192937541","media":"Wall Street Journal","summary":"U.S. stock futures edged down as investors assessed the latest headlines on restrictions to limit th","content":"<p>U.S. stock futures edged down as investors assessed the latest headlines on restrictions to limit the spread of the Omicron variant.</p>\n<p>Futures tied to the S&amp;P 500 retreated 0.3% Thursday, suggesting the broad-market index is set to pull back moderately after&nbsp;closing up 0.3% Wednesday. Dow Jones Industrial Average futures also slid 0.3% and Nasdaq-100 futures ticked down 0.2%.</p>\n<p>Stocks have swung in recent weeks, buffeted by conflicting headlines on the Omicron coronavirus variant and mixed signals on the health of the economy. Investors are still awaiting further data on the strain’s severity and vaccine efficacy. Some pharmaceutical companies including&nbsp;Pfizer&nbsp;and&nbsp;Glaxo&nbsp;Smith&nbsp;Kline&nbsp;have said this week that their shot and antibody treatment appears to work in early-stage studies.</p>\n<p>European governments have moved to tighten restrictions, spurring concerns about setbacks to the economic recovery. U.K. Prime Minister Johnson outlined a new&nbsp;work-from-home mandate&nbsp;and mask guidelines on Wednesday evening. A study released by a Japanese scientist said the variant was four times more transmissible than the Delta strain.</p>\n<p>“There’s still a lot we don’t know, we’re waiting for details to emerge,” said Arun Sai, a multi-asset strategist at Pictet Asset Management. On restrictions, “as long as it’s temporary, it doesn’t completely derail the recovery. We now know the playbook. We’re talking about a one or two quarter postponement of a recovery in services, that’s the critical element that’s at risk here.”</p>\n<p>The yield on the benchmark 10-year Treasury note edged down to 1.494% Thursday from 1.508% Wednesday.</p>\n<p>China’s producer-price index showed a&nbsp;12.9% increase in November&nbsp;from a year earlier, a decline from the previous month but still more than economists expected. Consumer prices also rose.</p>\n<p>“Factory gate prices only showed modest signs of slowing,” which may signal that higher inflation will remain in place in the coming months, said Michael Hewson, a chief markets analyst at CMC Markets. China’s producer prices drive consumer prices around the world, he added.</p>\n<p>In Asia, major benchmarks were mixed. The Shanghai Composite Index advanced 1%, while Hong Kong’s Hang Seng Index climbed 1.1%. Japan’s Nikkei 225 slid 0.5%, boosted by gains in technology stocks.</p>\n<p>In Europe, the pan-continental Stoxx Europe 600 ticked up 0.2%. Rolls Royce shares declined 4.4% after the company released an update that showed it had a long way to go before meeting its cash-flow target and which will depend on international travel being allowed, Mr. Hewson said.</p>\n<p>In the U.S., cloud-computing firmOracle,&nbsp;network company&nbsp;Broadcom&nbsp;and wholesaler Costco are set to report Thursday after market close. Popular meme stock&nbsp;GameStop&nbsp;declined 3.2% in off-hours trading after the company posted earnings that showed a&nbsp;widening loss last quarter.</p>\n<p>“Earnings have been strong overall, it’s a really positive underlying driver for equity markets,” said Kiran Ganesh, a multi-asset strategist at UBS Global Wealth Management.</p>\n<p>Shares of&nbsp;Amazon.com&nbsp;declined 0.2% premarket after the Italian government fined it $1.3 billion for&nbsp;alleged abuse of market dominance. The European Union is also investigating the e-commerce giant in a similar antitrust case.</p>\n<p>Fresh data on U.S. jobless claims, a proxy for layoffs, is set to go out at 8:30 a.m. ET. Economists are forecasting that the level will remain near pandemic lows. It has come close to the pre-pandemic average in recent weeks in a sign that the labor market is improving.</p>\n<p>Oil prices wavered between small gains and losses. Global benchmark Brent crude declined 0.2% and traded at $75.61 a barrel. It has risen more than 8% this week, lifted by early indications that the Omicron variant may not weigh on energy demand as much as feared, according to analysts at ANZ.</p>\n<p>Bitcoin reversed direction after four days of gains, slipping 2% from its level at 5 p.m. Wednesday. It traded below $50,000, a 28% drop from its record high set in November.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Stock Futures Wobble on Omicron Restrictions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Stock Futures Wobble on Omicron Restrictions\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-09 18:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/global-stock-markets-dow-update-12-09-2021-11639038586?mod=markets_lead_pos4><strong>Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. stock futures edged down as investors assessed the latest headlines on restrictions to limit the spread of the Omicron variant.\nFutures tied to the S&P 500 retreated 0.3% Thursday, suggesting the...</p>\n\n<a href=\"https://www.wsj.com/articles/global-stock-markets-dow-update-12-09-2021-11639038586?mod=markets_lead_pos4\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.wsj.com/articles/global-stock-markets-dow-update-12-09-2021-11639038586?mod=markets_lead_pos4","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192937541","content_text":"U.S. stock futures edged down as investors assessed the latest headlines on restrictions to limit the spread of the Omicron variant.\nFutures tied to the S&P 500 retreated 0.3% Thursday, suggesting the broad-market index is set to pull back moderately after closing up 0.3% Wednesday. Dow Jones Industrial Average futures also slid 0.3% and Nasdaq-100 futures ticked down 0.2%.\nStocks have swung in recent weeks, buffeted by conflicting headlines on the Omicron coronavirus variant and mixed signals on the health of the economy. Investors are still awaiting further data on the strain’s severity and vaccine efficacy. Some pharmaceutical companies including Pfizer and Glaxo Smith Kline have said this week that their shot and antibody treatment appears to work in early-stage studies.\nEuropean governments have moved to tighten restrictions, spurring concerns about setbacks to the economic recovery. U.K. Prime Minister Johnson outlined a new work-from-home mandate and mask guidelines on Wednesday evening. A study released by a Japanese scientist said the variant was four times more transmissible than the Delta strain.\n“There’s still a lot we don’t know, we’re waiting for details to emerge,” said Arun Sai, a multi-asset strategist at Pictet Asset Management. On restrictions, “as long as it’s temporary, it doesn’t completely derail the recovery. We now know the playbook. We’re talking about a one or two quarter postponement of a recovery in services, that’s the critical element that’s at risk here.”\nThe yield on the benchmark 10-year Treasury note edged down to 1.494% Thursday from 1.508% Wednesday.\nChina’s producer-price index showed a 12.9% increase in November from a year earlier, a decline from the previous month but still more than economists expected. Consumer prices also rose.\n“Factory gate prices only showed modest signs of slowing,” which may signal that higher inflation will remain in place in the coming months, said Michael Hewson, a chief markets analyst at CMC Markets. China’s producer prices drive consumer prices around the world, he added.\nIn Asia, major benchmarks were mixed. The Shanghai Composite Index advanced 1%, while Hong Kong’s Hang Seng Index climbed 1.1%. Japan’s Nikkei 225 slid 0.5%, boosted by gains in technology stocks.\nIn Europe, the pan-continental Stoxx Europe 600 ticked up 0.2%. Rolls Royce shares declined 4.4% after the company released an update that showed it had a long way to go before meeting its cash-flow target and which will depend on international travel being allowed, Mr. Hewson said.\nIn the U.S., cloud-computing firmOracle, network company Broadcom and wholesaler Costco are set to report Thursday after market close. Popular meme stock GameStop declined 3.2% in off-hours trading after the company posted earnings that showed a widening loss last quarter.\n“Earnings have been strong overall, it’s a really positive underlying driver for equity markets,” said Kiran Ganesh, a multi-asset strategist at UBS Global Wealth Management.\nShares of Amazon.com declined 0.2% premarket after the Italian government fined it $1.3 billion for alleged abuse of market dominance. The European Union is also investigating the e-commerce giant in a similar antitrust case.\nFresh data on U.S. jobless claims, a proxy for layoffs, is set to go out at 8:30 a.m. ET. Economists are forecasting that the level will remain near pandemic lows. It has come close to the pre-pandemic average in recent weeks in a sign that the labor market is improving.\nOil prices wavered between small gains and losses. Global benchmark Brent crude declined 0.2% and traded at $75.61 a barrel. It has risen more than 8% this week, lifted by early indications that the Omicron variant may not weigh on energy demand as much as feared, according to analysts at ANZ.\nBitcoin reversed direction after four days of gains, slipping 2% from its level at 5 p.m. Wednesday. It traded below $50,000, a 28% drop from its record high set in November.","news_type":1},"isVote":1,"tweetType":1,"viewCount":522,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602300738,"gmtCreate":1638966528449,"gmtModify":1638966528566,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602300738","repostId":"1177589023","repostType":4,"isVote":1,"tweetType":1,"viewCount":523,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602994187,"gmtCreate":1638953822873,"gmtModify":1638953823034,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602994187","repostId":"2189663242","repostType":4,"isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608834806,"gmtCreate":1638677115521,"gmtModify":1638677115594,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608834806","repostId":"1140678193","repostType":4,"isVote":1,"tweetType":1,"viewCount":107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609636649,"gmtCreate":1638276799478,"gmtModify":1638276799590,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Not cool","listText":"Not cool","text":"Not cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609636649","repostId":"2187589177","repostType":4,"repost":{"id":"2187589177","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638271821,"share":"https://www.laohu8.com/m/news/2187589177?lang=&edition=full","pubTime":"2021-11-30 19:30","market":"us","language":"en","title":"'This is not going to be good' -- Moderna CEO on what scientists are telling him about the omicron coronavirus variant","url":"https://stock-news.laohu8.com/highlight/detail?id=2187589177","media":"Dow Jones","summary":"Moderna CEO Stephane Bancel has left no doubt whether he's taking a glass half-full or half-empty ap","content":"<p>Moderna&nbsp;CEO Stephane Bancel has left no doubt whether he's taking a glass half-full or half-empty approach to the emergence of the new omicron coronavirus variant.</p>\n<p>He told the Financial Times there's no world where current vaccines are as effective as against the delta variant. And he suggested the dropoff could be significant.</p>\n<p></p>\n<blockquote>\n “I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to . . . are like, ‘This is not going to be good’.”\n</blockquote>\n<p></p>\n<p>The interview put another scare into financial markets, with futures on the Dow industrials contract losing more than 500 points. \"The major vaccine makers have offered timelines of two to six weeks for assessing its vaccine evading capabilities, and in the meantime, travel shutdowns and behaviour modification are a risk as we await anecdotal and statistical evidence of the spread of the virus and its virulence,\" said Steen Jakobsen, chief investment officer at Saxo Bank.</p>\n<p>Moderna had previously announced that data on the abillity of its vaccine to neutralize omicron variant would be expected in weeks as it works to rapidly advance a booster candidate specifically against the variant.</p>\n<p>Product sales from its coronavirus vaccine accounted for $4.81 billion of Moderna's $4.97 billion in revenue in the third quarter.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>'This is not going to be good' -- Moderna CEO on what scientists are telling him about the omicron coronavirus variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n'This is not going to be good' -- Moderna CEO on what scientists are telling him about the omicron coronavirus variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-30 19:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna&nbsp;CEO Stephane Bancel has left no doubt whether he's taking a glass half-full or half-empty approach to the emergence of the new omicron coronavirus variant.</p>\n<p>He told the Financial Times there's no world where current vaccines are as effective as against the delta variant. And he suggested the dropoff could be significant.</p>\n<p></p>\n<blockquote>\n “I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to . . . are like, ‘This is not going to be good’.”\n</blockquote>\n<p></p>\n<p>The interview put another scare into financial markets, with futures on the Dow industrials contract losing more than 500 points. \"The major vaccine makers have offered timelines of two to six weeks for assessing its vaccine evading capabilities, and in the meantime, travel shutdowns and behaviour modification are a risk as we await anecdotal and statistical evidence of the spread of the virus and its virulence,\" said Steen Jakobsen, chief investment officer at Saxo Bank.</p>\n<p>Moderna had previously announced that data on the abillity of its vaccine to neutralize omicron variant would be expected in weeks as it works to rapidly advance a booster candidate specifically against the variant.</p>\n<p>Product sales from its coronavirus vaccine accounted for $4.81 billion of Moderna's $4.97 billion in revenue in the third quarter.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4568":"美国抗疫概念","BK4532":"文艺复兴科技持仓","MRNA":"Moderna, Inc.","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187589177","content_text":"Moderna CEO Stephane Bancel has left no doubt whether he's taking a glass half-full or half-empty approach to the emergence of the new omicron coronavirus variant.\nHe told the Financial Times there's no world where current vaccines are as effective as against the delta variant. And he suggested the dropoff could be significant.\n\n\n “I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to . . . are like, ‘This is not going to be good’.”\n\n\nThe interview put another scare into financial markets, with futures on the Dow industrials contract losing more than 500 points. \"The major vaccine makers have offered timelines of two to six weeks for assessing its vaccine evading capabilities, and in the meantime, travel shutdowns and behaviour modification are a risk as we await anecdotal and statistical evidence of the spread of the virus and its virulence,\" said Steen Jakobsen, chief investment officer at Saxo Bank.\nModerna had previously announced that data on the abillity of its vaccine to neutralize omicron variant would be expected in weeks as it works to rapidly advance a booster candidate specifically against the variant.\nProduct sales from its coronavirus vaccine accounted for $4.81 billion of Moderna's $4.97 billion in revenue in the third quarter.","news_type":1},"isVote":1,"tweetType":1,"viewCount":347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609633796,"gmtCreate":1638276474074,"gmtModify":1638276474139,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609633796","repostId":"1183198352","repostType":4,"repost":{"id":"1183198352","pubTimestamp":1638274451,"share":"https://www.laohu8.com/m/news/1183198352?lang=&edition=full","pubTime":"2021-11-30 20:14","market":"us","language":"en","title":"Apple Stock: Here's Your Chance To Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=1183198352","media":"Seeking Alpha","summary":"Summary\n\nAAPL has returned to strong price support, and I believe it will turn higher from here.\nThe","content":"<p><b>Summary</b></p>\n<ul>\n <li>AAPL has returned to strong price support, and I believe it will turn higher from here.</li>\n <li>The company's fundamentals continue to improve in a variety of ways, and supply chain issues are just noise.</li>\n <li>The stock is a buy and I believe will make new all-time highs in the relatively near future.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eee640d38ca964a8a25d978d1f858293\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>AleksandarNakic/iStock Unreleased via Getty Images</span></p>\n<p>The selloff that took place last Friday was certainly unexpected. A new COVID variant is never a good thing - for a variety of reasons - and the market sold first and asked questions later. The good news is that selling created some great entry points on leading stocks, and in this article, I'll update my views on technology mothership&nbsp;<b>Apple</b>(AAPL), which I believe just hit very strong support, and is now ready for a run to a new all-time high.</p>\n<p>Apple has been a model portfolio stock in my Seeking Alpha Marketplace service,<i>Timely Trader</i>, since the service's inception, and by all evidence, appears poised to maintain its position. The portfolio is re-evaluated every month to ensure our capital is deployed effectively, and Apple continues to make the cut. Below I'll explain why the noise around the supply chain is just that, and why the stock has positioned itself for continued highs into 2022.</p>\n<p><img src=\"https://static.tigerbbs.com/98a005c1e28b33227395e295eb4d3ac6\" tg-width=\"640\" tg-height=\"812\" width=\"100%\" height=\"auto\"></p>\n<p>We'll take a brief look at the chart, because I think this pretty clearly illustrates why Apple is a buy right now. First, the stock made a new all-time high earlier this month on very heavy volume, which is a bullish trait. It means buyers were out in force while the share price was rising, indicating a lot of market participation with the new high. That coincided with a new high in the accumulation/distribution line, which measures whether the stock is finishing nearer to the high or low for the day. A higher A/D line means buyers are active during the day, and is another bullish trait; Apple is exhibiting this as well.</p>\n<p>The stock was overbought during the rally - as measured by the 14-day RSI - but has since pulled back meaningfully during this consolidation. That's completely expected and totally fine, as it means the bulls can now make another run higher. And finally, the PPO is in very bullish territory, and is continuing to move higher, so I see no issues with momentum despite the recent pullback.</p>\n<p>In short, Apple's chart looks great, and with support at ~$157, which was the prior breakout level, as well as the rising 20-day EMA (in red above), I see a lot of reasons to be bullish today.</p>\n<p>Now, let's take a look at the fundamental case for Apple, which I think remains as strong as it has ever been.</p>\n<p><b>Ignore the noise, Apple is still dominant</b></p>\n<p>Apple's&nbsp;Q4 earnings&nbsp;showed a rare revenue miss and profit number that was only in line with expectations, which is quite unusual for this juggernaut. However, as we all know, Apple and others are being heavily impacted by supply chain woes that have absolutely taken over the conversation when it comes to the economy in recent months. Apple, like any other manufacturer, needs its supply chain to be functioning at full speed in order to maximize revenue, but these things are largely out of its control. Apple suffered for that in Q4, but instead of focusing on the report itself, which you can read all about in a variety of places, let's look at how Apple may respond in the fiscal year that just began.</p>\n<p>There is&nbsp;evidence&nbsp;to suggest that Apple's supply chain issues that negatively impacted the fourth quarter, and indeed, October as well, are abating. Keep in mind that Apple's suppliers have massive incentives to keep their components flowing to Apple to make phones and other devices, so there are literally thousands of people across the world working to address Apple's supply chain issues. With the iPhone 13 cycle ramping up, and&nbsp;China&nbsp;showing strong demand for Apple products once again, all looks well.</p>\n<p>Keep in mind also that selling the stock because Apple cannot keep up with demand is a bit counterintuitive. Generally, you want to sell stocks that have too much supply and not enough demand; Apple has the opposite problem, which indicates two things. First, pricing power should remain quite strong given the demand/supply imbalance, and second, when supply does catch up to demand, we'll see higher volumes at strong prices. Why would you sell a stock with these characteristics?</p>\n<p>Now, let's take a look at revenue estimates to see how analysts see Apple moving forward given the supply chain issues are well-known.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4e4ee0e69bc003794d9ef8a801403a88\" tg-width=\"640\" tg-height=\"281\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha</span></p>\n<p>We can see that Apple's estimates continue to move up and to the right, although one could argue the pace of increases has slowed. That's okay, because the important thing is that we continue to see higher and higher revenue estimates for the years to come. I'd also offer that Apple has generally performed quite well against revenue estimates, which is why Q4's revenue miss took people by surprise. I'll reiterate the revenue miss was due to supply chain issues outside of the company's control, and therefore shouldn't be blown out of proportion; it's transitory.</p>\n<p>Now, another key to the bull thesis is that Apple's margins are&nbsp;<i>flying</i>, which we can see below. I've plotted trailing-twelve-months revenue and operating margins to illustrate how operating leverage is working for Apple.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bbaba8826e257af5666c27d29b2f18cf\" tg-width=\"640\" tg-height=\"167\" width=\"100%\" height=\"auto\"><span>Source: TIKR.com</span></p>\n<p>Revenue on a TTM basis was actually pretty flat for a couple of years, but in the past handful of quarters, has flown higher. With that, operating margins have moved significantly higher as well, with the September 2020 quarter posting 24% operating margins, while this year's September quarter posting TTM margins of 30%. That's a 25% increase in the amount of profit per dollar of revenue Apple produces, which is enormous to say the least. And as we'll see in just a moment, those gains look set to continue.</p>\n<p>Below we have TTM gross margins and SG&amp;A costs, which are the two main components of operating margins, to illustrate how Apple has achieved its profitability gains.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/af4bc2b49806742ed776ba5e76577543\" tg-width=\"640\" tg-height=\"166\" width=\"100%\" height=\"auto\"><span>Source: TIKR.com</span></p>\n<p>SG&amp;A costs have declined from just over 7% of revenue to only 6% of revenue as of the most recent quarter, while gross margins are up from ~38% to ~42% in the same period. That means Apple is gaining on both sides of the equation, showing strong margins through pricing power, and reducing relative costs to produce revenue. This is how Apple has managed to boost profitability so much in the past few quarters, and it all hinges upon higher revenue.</p>\n<p>The bottom line is that so long as revenue is rising, we should see steady or higher gross margins, and lower SG&amp;A costs. These things combine to create higher profitability per dollar of revenue, so we get this supercharged impact on earnings growth where revenue is higher, and the profit per dollar is higher. If you're an Apple bull, you want to keep your eye on revenue because it's driving everything.</p>\n<p>Switching gears, Apple has been a very strong returner of capital in recent years, and that is no different today. The dividend is pretty small and meaningless at this point, but the company's efforts to reduce the float are anything but.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/02926f966d571a5d9af3865b5534bd75\" tg-width=\"640\" tg-height=\"168\" width=\"100%\" height=\"auto\"><span>Source: TIKR.com</span></p>\n<p>We can see the share count is<i>36% lower</i>than it was in 2012, which means that on a per-share basis, Apple's earnings are worth 36% more than they otherwise would be. Apple has far more cash than it could ever profitably reinvest in the business, and it produces more and more every year. That means we'll almost certainly see this continue to dwindle, providing a constant tailwind to EPS every year.</p>\n<p>We therefore have ever-rising revenue, rising margins, and a lower share count, all of which support higher EPS. It is no surprise then that Apple's EPS revisions look the way they do.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b562a3b59264989d5077b069db4633ad\" tg-width=\"640\" tg-height=\"286\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha</span></p>\n<p>This is exactly what you want to see, and it's the product of a company that continues to outperform expectations, intelligently return capital to shareholders, and continue to create and market world-class products that consumers cannot get enough of.</p>\n<p><b>Valuation reset creates a buying chance</b></p>\n<p>Now, we all know valuations are stretched in a lot of places for a lot of different stocks, and Apple is no different. We can see below that its forward PE is 28X today, versus a three-year average of 23X. However, it's well off its high of 37X, and I'd argue that given its acceleration of revenue and margins, Apple should be more highly valued than it was in the past three years. The simple fact is that the company's earnings stream has improved greatly, so why shouldn't the valuation?</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e3375c0e3b0081634279d2f828195612\" tg-width=\"640\" tg-height=\"194\" width=\"100%\" height=\"auto\"><span>Source: TIKR.com</span></p>\n<p>Given the company's growth trajectory, and including the fact that we should see some pent-up demand from fiscal 2021 moved into fiscal 2022 due to supply chain issues, I see this valuation as quite enticing. In fact, I think there's a lot more upside potential to 28X earnings than there is downside potential, so when we combine the technical picture with the fundamentals - including this valuation - I cannot see any path other than a bullish one for Apple.</p>\n<p>I'm certainly no Apple perma-bull, but when I objectively evaluate this company's prospects and the outlook for the stock, I can only reach one conclusion: it's a buy on its way to new all-time highs.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: Here's Your Chance To Buy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: Here's Your Chance To Buy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4472312-apple-heres-your-chance><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nAAPL has returned to strong price support, and I believe it will turn higher from here.\nThe company's fundamentals continue to improve in a variety of ways, and supply chain issues are just ...</p>\n\n<a href=\"https://seekingalpha.com/article/4472312-apple-heres-your-chance\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4472312-apple-heres-your-chance","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183198352","content_text":"Summary\n\nAAPL has returned to strong price support, and I believe it will turn higher from here.\nThe company's fundamentals continue to improve in a variety of ways, and supply chain issues are just noise.\nThe stock is a buy and I believe will make new all-time highs in the relatively near future.\n\nAleksandarNakic/iStock Unreleased via Getty Images\nThe selloff that took place last Friday was certainly unexpected. A new COVID variant is never a good thing - for a variety of reasons - and the market sold first and asked questions later. The good news is that selling created some great entry points on leading stocks, and in this article, I'll update my views on technology mothership Apple(AAPL), which I believe just hit very strong support, and is now ready for a run to a new all-time high.\nApple has been a model portfolio stock in my Seeking Alpha Marketplace service,Timely Trader, since the service's inception, and by all evidence, appears poised to maintain its position. The portfolio is re-evaluated every month to ensure our capital is deployed effectively, and Apple continues to make the cut. Below I'll explain why the noise around the supply chain is just that, and why the stock has positioned itself for continued highs into 2022.\n\nWe'll take a brief look at the chart, because I think this pretty clearly illustrates why Apple is a buy right now. First, the stock made a new all-time high earlier this month on very heavy volume, which is a bullish trait. It means buyers were out in force while the share price was rising, indicating a lot of market participation with the new high. That coincided with a new high in the accumulation/distribution line, which measures whether the stock is finishing nearer to the high or low for the day. A higher A/D line means buyers are active during the day, and is another bullish trait; Apple is exhibiting this as well.\nThe stock was overbought during the rally - as measured by the 14-day RSI - but has since pulled back meaningfully during this consolidation. That's completely expected and totally fine, as it means the bulls can now make another run higher. And finally, the PPO is in very bullish territory, and is continuing to move higher, so I see no issues with momentum despite the recent pullback.\nIn short, Apple's chart looks great, and with support at ~$157, which was the prior breakout level, as well as the rising 20-day EMA (in red above), I see a lot of reasons to be bullish today.\nNow, let's take a look at the fundamental case for Apple, which I think remains as strong as it has ever been.\nIgnore the noise, Apple is still dominant\nApple's Q4 earnings showed a rare revenue miss and profit number that was only in line with expectations, which is quite unusual for this juggernaut. However, as we all know, Apple and others are being heavily impacted by supply chain woes that have absolutely taken over the conversation when it comes to the economy in recent months. Apple, like any other manufacturer, needs its supply chain to be functioning at full speed in order to maximize revenue, but these things are largely out of its control. Apple suffered for that in Q4, but instead of focusing on the report itself, which you can read all about in a variety of places, let's look at how Apple may respond in the fiscal year that just began.\nThere is evidence to suggest that Apple's supply chain issues that negatively impacted the fourth quarter, and indeed, October as well, are abating. Keep in mind that Apple's suppliers have massive incentives to keep their components flowing to Apple to make phones and other devices, so there are literally thousands of people across the world working to address Apple's supply chain issues. With the iPhone 13 cycle ramping up, and China showing strong demand for Apple products once again, all looks well.\nKeep in mind also that selling the stock because Apple cannot keep up with demand is a bit counterintuitive. Generally, you want to sell stocks that have too much supply and not enough demand; Apple has the opposite problem, which indicates two things. First, pricing power should remain quite strong given the demand/supply imbalance, and second, when supply does catch up to demand, we'll see higher volumes at strong prices. Why would you sell a stock with these characteristics?\nNow, let's take a look at revenue estimates to see how analysts see Apple moving forward given the supply chain issues are well-known.\nSource: Seeking Alpha\nWe can see that Apple's estimates continue to move up and to the right, although one could argue the pace of increases has slowed. That's okay, because the important thing is that we continue to see higher and higher revenue estimates for the years to come. I'd also offer that Apple has generally performed quite well against revenue estimates, which is why Q4's revenue miss took people by surprise. I'll reiterate the revenue miss was due to supply chain issues outside of the company's control, and therefore shouldn't be blown out of proportion; it's transitory.\nNow, another key to the bull thesis is that Apple's margins are flying, which we can see below. I've plotted trailing-twelve-months revenue and operating margins to illustrate how operating leverage is working for Apple.\nSource: TIKR.com\nRevenue on a TTM basis was actually pretty flat for a couple of years, but in the past handful of quarters, has flown higher. With that, operating margins have moved significantly higher as well, with the September 2020 quarter posting 24% operating margins, while this year's September quarter posting TTM margins of 30%. That's a 25% increase in the amount of profit per dollar of revenue Apple produces, which is enormous to say the least. And as we'll see in just a moment, those gains look set to continue.\nBelow we have TTM gross margins and SG&A costs, which are the two main components of operating margins, to illustrate how Apple has achieved its profitability gains.\nSource: TIKR.com\nSG&A costs have declined from just over 7% of revenue to only 6% of revenue as of the most recent quarter, while gross margins are up from ~38% to ~42% in the same period. That means Apple is gaining on both sides of the equation, showing strong margins through pricing power, and reducing relative costs to produce revenue. This is how Apple has managed to boost profitability so much in the past few quarters, and it all hinges upon higher revenue.\nThe bottom line is that so long as revenue is rising, we should see steady or higher gross margins, and lower SG&A costs. These things combine to create higher profitability per dollar of revenue, so we get this supercharged impact on earnings growth where revenue is higher, and the profit per dollar is higher. If you're an Apple bull, you want to keep your eye on revenue because it's driving everything.\nSwitching gears, Apple has been a very strong returner of capital in recent years, and that is no different today. The dividend is pretty small and meaningless at this point, but the company's efforts to reduce the float are anything but.\nSource: TIKR.com\nWe can see the share count is36% lowerthan it was in 2012, which means that on a per-share basis, Apple's earnings are worth 36% more than they otherwise would be. Apple has far more cash than it could ever profitably reinvest in the business, and it produces more and more every year. That means we'll almost certainly see this continue to dwindle, providing a constant tailwind to EPS every year.\nWe therefore have ever-rising revenue, rising margins, and a lower share count, all of which support higher EPS. It is no surprise then that Apple's EPS revisions look the way they do.\nSource: Seeking Alpha\nThis is exactly what you want to see, and it's the product of a company that continues to outperform expectations, intelligently return capital to shareholders, and continue to create and market world-class products that consumers cannot get enough of.\nValuation reset creates a buying chance\nNow, we all know valuations are stretched in a lot of places for a lot of different stocks, and Apple is no different. We can see below that its forward PE is 28X today, versus a three-year average of 23X. However, it's well off its high of 37X, and I'd argue that given its acceleration of revenue and margins, Apple should be more highly valued than it was in the past three years. The simple fact is that the company's earnings stream has improved greatly, so why shouldn't the valuation?\nSource: TIKR.com\nGiven the company's growth trajectory, and including the fact that we should see some pent-up demand from fiscal 2021 moved into fiscal 2022 due to supply chain issues, I see this valuation as quite enticing. In fact, I think there's a lot more upside potential to 28X earnings than there is downside potential, so when we combine the technical picture with the fundamentals - including this valuation - I cannot see any path other than a bullish one for Apple.\nI'm certainly no Apple perma-bull, but when I objectively evaluate this company's prospects and the outlook for the stock, I can only reach one conclusion: it's a buy on its way to new all-time highs.","news_type":1},"isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609639746,"gmtCreate":1638276296210,"gmtModify":1638276296311,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609639746","repostId":"2187581396","repostType":4,"repost":{"id":"2187581396","pubTimestamp":1638274712,"share":"https://www.laohu8.com/m/news/2187581396?lang=&edition=full","pubTime":"2021-11-30 20:18","market":"us","language":"en","title":"JPMorgan Says Omicron Won’t Stop the Global Equities Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581396","media":"Bloomberg","summary":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; ","content":"<ul>\n <li>Strategists expect post-Covid normalization to assert itself</li>\n <li>See 9% upside for S&amp;P 500 by end-2022; 17% for Eurozone stocks</li>\n</ul>\n<p>Omicron won’t derail the rally for global stocks, according to JPMorgan Chase &amp; Co. strategists, adding another voice to the tone of&nbsp;cautious optimism&nbsp;in the market after the recent sharp pullback.</p>\n<p>“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.</p>\n<p>European and Asian stocks, along with U.S. equity futures, fell on Tuesday after&nbsp;Moderna Inc.&nbsp;executives confirmed that the omicron coronavirus variant&nbsp;could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.</p>\n<p><img src=\"https://static.tigerbbs.com/9fb3f6e11f7c305d036b47b9ae9eb2e5\" tg-width=\"889\" tg-height=\"501\" width=\"100%\" height=\"auto\"></p>\n<p>Unfazed by the latest scare, JPMorgan’s strategists forecast that the S&amp;P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.</p>\n<p>The strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.</p>\n<p>They singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Says Omicron Won’t Stop the Global Equities Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Says Omicron Won’t Stop the Global Equities Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","JPM":"摩根大通","BK4504":"桥水持仓","BK4550":"红杉资本持仓",".DJI":"道琼斯","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团",".SPX":"S&P 500 Index","BK4207":"综合性银行",".IXIC":"NASDAQ Composite","MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-11-30/jpmorgan-says-omicron-won-t-stop-the-global-equities-rally","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581396","content_text":"Strategists expect post-Covid normalization to assert itself\nSee 9% upside for S&P 500 by end-2022; 17% for Eurozone stocks\n\nOmicron won’t derail the rally for global stocks, according to JPMorgan Chase & Co. strategists, adding another voice to the tone of cautious optimism in the market after the recent sharp pullback.\n“Sporadic setbacks,” such as the emergence of omicron should be viewed “in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,” strategists led by Dubravko Lakos-Bujas and Mislav Matejka wrote in a note. “We expect post-Covid normalization to continue to assert itself globally in 2022,” they said.\nEuropean and Asian stocks, along with U.S. equity futures, fell on Tuesday after Moderna Inc. executives confirmed that the omicron coronavirus variant could evade existing vaccines. Research is still underway to determine if the new strain is as virulent as its predecessors, while developers including Moderna, Pfizer Inc. and BioNTech SE are working on potentially updated versions of their shots.\n\nUnfazed by the latest scare, JPMorgan’s strategists forecast that the S&P 500 Index will gain about 9% from its current levels to climb to 5,050 by end-2022. “We continue to see market upside, though more moderate, on better-than-expected earnings growth with supply shocks easing, China/EM backdrop improving, and normalizing consumer spending habits,” they wrote in their year-ahead outlook note.\nThe strategists expect European equities to outperform U.S., Chinese stocks to fare better than emerging markets, and emerging markets to outpace developed ones.\nThey singled out a hawkish shift by central banks, rather than Covid-19, as the key risk to their bullish outlook, while recommending that investors retain a pro-cyclical tilt, with a preference for energy and financials, consumer services, and small caps. They favor healthcare over other defensive sectors.","news_type":1},"isVote":1,"tweetType":1,"viewCount":316,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600452530,"gmtCreate":1638192258207,"gmtModify":1638192300823,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600452530","repostId":"1132472721","repostType":4,"repost":{"id":"1132472721","pubTimestamp":1638188371,"share":"https://www.laohu8.com/m/news/1132472721?lang=&edition=full","pubTime":"2021-11-29 20:19","market":"us","language":"en","title":"Plug Power Stock Looks Promising, But Don’t Get Too Excited Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1132472721","media":"InvestorPlace","summary":"PLUG stock won't be profitable for a while, but it's worth the wait","content":"<p>Since reporting third-quarter results on Nov. 9,<b>Plug Power</b>(NASDAQ:<b><u>PLUG</u></b>) stock has been volatile, trading in a 20% range.</p>\n<p>The share price has been as low as $39, and as high as $45, as investors balance losses and growth with the promise of the “green hydrogen” market.</p>\n<p>For the three months ending in September, Plug Power&nbsp;lost $106 million, 19 cents per share, on revenue of $144 million. A year earlier it lost $65 million, 18 cents per share, on revenue of $107 million.</p>\n<p>Revenue grew 34%, but losses also grew from 60% of revenue to almost 74%. The loss would have been worse except for sales of new stock. Yet shares are up 4.5% over where they were when earnings were announced, thanks mainly to the promise of “green” hydrogen.</p>\n<p><b>A Closer Look at PLUG Stock</b></p>\n<p>Hydrogen doesn’t really come in multiple colors. It’s just defined that way for market purposes.</p>\n<p>“Blue” hydrogen uses&nbsp;natural gas&nbsp;as a feedstock. Green hydrogen uses electricity to split water molecules into its constituent atoms, which are oxygen and hydrogen.</p>\n<p>Hydrogen is used in fuel cells to deliver power by reversing the green hydrogen process. Hydrogen in the fuel cell combines with oxygen in the air, creating electricity with water as the byproduct.</p>\n<p>Plug Power began by making these fuel cells&nbsp;mainly for forklifts in warehouses. Hydrogen beats electricity in warehouses for range and both beat fossil fuels for cleanliness.</p>\n<p>Plug Power decided last year to focus on becoming&nbsp;a green hydrogen supplier, starting with an&nbsp;<b>Olin</b>(NYSE:<b><u>OLN</u></b>) Chlor-alkali plant in Tennessee.</p>\n<p>The Olin plant was already separating water, using electrolysis, to create caustic soda and chlorine from brine. A Plug Power acquisition called United Hydrogen was able to collect the hydrogen, while another new unit called Giner ELX could sell it.</p>\n<p>This year, Plug Power is taking its green hydrogen ideas global. It has a partnership to create plants&nbsp;in Europe. It’s building a plant&nbsp;in Australia. It’s also building a fuel cell manufacturing plant&nbsp;in New York state.</p>\n<p>TV analyst Jim Cramer has called the environmental trend represented by Plug Power “unstoppable.”</p>\n<p><b>Green Versus Blue Hydrogen</b></p>\n<p>Analysts are also arguing about green and blue regarding Plug Power, but this argument involves whether to invest green money or feel blue about its prospects.</p>\n<p><b>Citigroup</b>(NYSE:<b><u>C</u></b>) recently promoted&nbsp;a trade&nbsp;to buy Plug Power while shorting a competitor,<b>Ballard Systems</b>(NASDAQ:<b><u>BLDP</u></b>). This helped give Plug Power&nbsp;its post-earnings gain.</p>\n<p>For the year Plug Power’s performance now matches that of the S&amp;P 500, with both up 26%. But Plug Power has been as high as $69 on optimism over green hydrogen.</p>\n<p>It’s been as low as $23 on financial results.</p>\n<p>While the stock is hot, Plug Power is also adding to its portfolio. It has completed the October purchase of&nbsp;Applied Cryo Technologies, which helps store and move gas in liquid form.</p>\n<p>The conflict between blue and green can be found in the fact that Applied Cryo is&nbsp;a Houston company.</p>\n<p><b>The Bottom Line</b></p>\n<p>I have written that Plug Power is&nbsp;a long-term play. &nbsp;You can buy and sell it as a trade, but you can also choose to invest in its plans to build a vertically-integrated green hydrogen solution, which it calls GenKey.</p>\n<p>GenKey will encompass the creation, distribution, and direct sale of hydrogen through a common infrastructure.</p>\n<p>It’s a different business model from the forklifts Plug Power began with. It takes advantage of all demand from hydrogen fuel cells, including that from&nbsp;<b>FuelCell Systems</b>(NASDAQ:<b><u>FCEL</u></b>), with which it has been compared in the past.</p>\n<p>If you believe in the promise of hydrogen, produced without natural gas, as a profitable fuel stock, Plug Power is the stock you want to own.</p>\n<p>Just remember that profits, if they ever arrive, are still on the distant horizon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Plug Power Stock Looks Promising, But Don’t Get Too Excited Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPlug Power Stock Looks Promising, But Don’t Get Too Excited Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 20:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/11/plus-stock-looks-promising-but-dont-get-too-excited/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since reporting third-quarter results on Nov. 9,Plug Power(NASDAQ:PLUG) stock has been volatile, trading in a 20% range.\nThe share price has been as low as $39, and as high as $45, as investors ...</p>\n\n<a href=\"https://investorplace.com/2021/11/plus-stock-looks-promising-but-dont-get-too-excited/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLUG":"普拉格能源"},"source_url":"https://investorplace.com/2021/11/plus-stock-looks-promising-but-dont-get-too-excited/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132472721","content_text":"Since reporting third-quarter results on Nov. 9,Plug Power(NASDAQ:PLUG) stock has been volatile, trading in a 20% range.\nThe share price has been as low as $39, and as high as $45, as investors balance losses and growth with the promise of the “green hydrogen” market.\nFor the three months ending in September, Plug Power lost $106 million, 19 cents per share, on revenue of $144 million. A year earlier it lost $65 million, 18 cents per share, on revenue of $107 million.\nRevenue grew 34%, but losses also grew from 60% of revenue to almost 74%. The loss would have been worse except for sales of new stock. Yet shares are up 4.5% over where they were when earnings were announced, thanks mainly to the promise of “green” hydrogen.\nA Closer Look at PLUG Stock\nHydrogen doesn’t really come in multiple colors. It’s just defined that way for market purposes.\n“Blue” hydrogen uses natural gas as a feedstock. Green hydrogen uses electricity to split water molecules into its constituent atoms, which are oxygen and hydrogen.\nHydrogen is used in fuel cells to deliver power by reversing the green hydrogen process. Hydrogen in the fuel cell combines with oxygen in the air, creating electricity with water as the byproduct.\nPlug Power began by making these fuel cells mainly for forklifts in warehouses. Hydrogen beats electricity in warehouses for range and both beat fossil fuels for cleanliness.\nPlug Power decided last year to focus on becoming a green hydrogen supplier, starting with an Olin(NYSE:OLN) Chlor-alkali plant in Tennessee.\nThe Olin plant was already separating water, using electrolysis, to create caustic soda and chlorine from brine. A Plug Power acquisition called United Hydrogen was able to collect the hydrogen, while another new unit called Giner ELX could sell it.\nThis year, Plug Power is taking its green hydrogen ideas global. It has a partnership to create plants in Europe. It’s building a plant in Australia. It’s also building a fuel cell manufacturing plant in New York state.\nTV analyst Jim Cramer has called the environmental trend represented by Plug Power “unstoppable.”\nGreen Versus Blue Hydrogen\nAnalysts are also arguing about green and blue regarding Plug Power, but this argument involves whether to invest green money or feel blue about its prospects.\nCitigroup(NYSE:C) recently promoted a trade to buy Plug Power while shorting a competitor,Ballard Systems(NASDAQ:BLDP). This helped give Plug Power its post-earnings gain.\nFor the year Plug Power’s performance now matches that of the S&P 500, with both up 26%. But Plug Power has been as high as $69 on optimism over green hydrogen.\nIt’s been as low as $23 on financial results.\nWhile the stock is hot, Plug Power is also adding to its portfolio. It has completed the October purchase of Applied Cryo Technologies, which helps store and move gas in liquid form.\nThe conflict between blue and green can be found in the fact that Applied Cryo is a Houston company.\nThe Bottom Line\nI have written that Plug Power is a long-term play.  You can buy and sell it as a trade, but you can also choose to invest in its plans to build a vertically-integrated green hydrogen solution, which it calls GenKey.\nGenKey will encompass the creation, distribution, and direct sale of hydrogen through a common infrastructure.\nIt’s a different business model from the forklifts Plug Power began with. It takes advantage of all demand from hydrogen fuel cells, including that from FuelCell Systems(NASDAQ:FCEL), with which it has been compared in the past.\nIf you believe in the promise of hydrogen, produced without natural gas, as a profitable fuel stock, Plug Power is the stock you want to own.\nJust remember that profits, if they ever arrive, are still on the distant horizon.","news_type":1},"isVote":1,"tweetType":1,"viewCount":193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877276657,"gmtCreate":1637939216050,"gmtModify":1637939216121,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Will this nightmare ever end !!!","listText":"Will this nightmare ever end !!!","text":"Will this nightmare ever end !!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877276657","repostId":"1125886564","repostType":4,"repost":{"id":"1125886564","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637938179,"share":"https://www.laohu8.com/m/news/1125886564?lang=&edition=full","pubTime":"2021-11-26 22:49","market":"us","language":"en","title":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1125886564","media":"Tiger Newspress","summary":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech ","content":"<p>Vaccine&nbsp;stocks&nbsp;continued&nbsp;to&nbsp;rise&nbsp;in&nbsp;early&nbsp;trading,&nbsp;Moderna&nbsp;shares&nbsp;surged&nbsp;more&nbsp;than&nbsp;23%&nbsp;and&nbsp;BioNTech&nbsp;jumped&nbsp;nearly&nbsp;19%.<img src=\"https://static.tigerbbs.com/2e9f40662925ec57d0176cf5f1e36df4\" tg-width=\"876\" tg-height=\"613\" referrerpolicy=\"no-referrer\">Germany's BioNTech &nbsp;said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.</p>\n<p>\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-26 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine&nbsp;stocks&nbsp;continued&nbsp;to&nbsp;rise&nbsp;in&nbsp;early&nbsp;trading,&nbsp;Moderna&nbsp;shares&nbsp;surged&nbsp;more&nbsp;than&nbsp;23%&nbsp;and&nbsp;BioNTech&nbsp;jumped&nbsp;nearly&nbsp;19%.<img src=\"https://static.tigerbbs.com/2e9f40662925ec57d0176cf5f1e36df4\" tg-width=\"876\" tg-height=\"613\" referrerpolicy=\"no-referrer\">Germany's BioNTech &nbsp;said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.</p>\n<p>\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125886564","content_text":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech jumped nearly 19%.Germany's BioNTech  said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.\n\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877092107,"gmtCreate":1637836540767,"gmtModify":1637836540832,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877092107","repostId":"1182200011","repostType":4,"isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874820271,"gmtCreate":1637759777894,"gmtModify":1637759777959,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874820271","repostId":"1122354427","repostType":4,"repost":{"id":"1122354427","pubTimestamp":1637749072,"share":"https://www.laohu8.com/m/news/1122354427?lang=&edition=full","pubTime":"2021-11-24 18:17","market":"us","language":"en","title":"Musk Passes Tesla Sale Halfway Point With $9.9 Billion Cashed In","url":"https://stock-news.laohu8.com/highlight/detail?id=1122354427","media":"Bloomberg","summary":"(Bloomberg) -- Elon Musk resumed selling shares in Tesla Inc. and passed the halfway point toward ma","content":"<p>(Bloomberg) -- Elon Musk resumed selling shares in Tesla Inc. and passed the halfway point toward making good on a plan to offload 10% of his stake in the electric-car maker.</p>\n<p>The billionaire offloaded another 934,091 shares for $1.05 billion, according to regulatory filings posted late Tuesday. The sales were carried out to cover taxes related to Musk exercising an additional 2.15 million stock options, the documents show.</p>\n<p>With the most recent disposals, Musk now has sold 9.2 million shares worth about $9.9 billion since he conducted a Twitter poll asking whether he should sell 10% of his Tesla holding. A chunk of that money will go to taxes.</p>\n<p>To reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’ll need to sell even more.</p>\n<p>Since the Twitter poll, Musk has exercised millions of options that were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. Musk didn’t mention the existence of that plan in his tweets early this month.</p>\n<p>Tesla shares were little changed as of 5 a.m. New York time Wednesday, before the start of regular trading. The shares have traded down about 9% since Musk’s poll.</p>\n<p>Musk, 50, is the world’s richest person with a $303.7 billion fortune, according to the Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year -- more than anyone else -- amid a 57% jump in Tesla shares.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk Passes Tesla Sale Halfway Point With $9.9 Billion Cashed In</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk Passes Tesla Sale Halfway Point With $9.9 Billion Cashed In\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-24 18:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/musk-now-sold-more-half-032154924.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Elon Musk resumed selling shares in Tesla Inc. and passed the halfway point toward making good on a plan to offload 10% of his stake in the electric-car maker.\nThe billionaire offloaded...</p>\n\n<a href=\"https://finance.yahoo.com/news/musk-now-sold-more-half-032154924.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://finance.yahoo.com/news/musk-now-sold-more-half-032154924.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122354427","content_text":"(Bloomberg) -- Elon Musk resumed selling shares in Tesla Inc. and passed the halfway point toward making good on a plan to offload 10% of his stake in the electric-car maker.\nThe billionaire offloaded another 934,091 shares for $1.05 billion, according to regulatory filings posted late Tuesday. The sales were carried out to cover taxes related to Musk exercising an additional 2.15 million stock options, the documents show.\nWith the most recent disposals, Musk now has sold 9.2 million shares worth about $9.9 billion since he conducted a Twitter poll asking whether he should sell 10% of his Tesla holding. A chunk of that money will go to taxes.\nTo reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’ll need to sell even more.\nSince the Twitter poll, Musk has exercised millions of options that were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. Musk didn’t mention the existence of that plan in his tweets early this month.\nTesla shares were little changed as of 5 a.m. New York time Wednesday, before the start of regular trading. The shares have traded down about 9% since Musk’s poll.\nMusk, 50, is the world’s richest person with a $303.7 billion fortune, according to the Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year -- more than anyone else -- amid a 57% jump in Tesla shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":323,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875035959,"gmtCreate":1637586258183,"gmtModify":1637586258285,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Takeoff","listText":"Takeoff","text":"Takeoff","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875035959","repostId":"1184820113","repostType":4,"repost":{"id":"1184820113","pubTimestamp":1637579778,"share":"https://www.laohu8.com/m/news/1184820113?lang=&edition=full","pubTime":"2021-11-22 19:16","market":"us","language":"en","title":"U.S. airlines, airports brace for busy Thanksgiving travel week","url":"https://stock-news.laohu8.com/highlight/detail?id=1184820113","media":"Reuters","summary":"WASHINGTON (Reuters) - U.S. airlines and airports braced for a surge of travelers ahead of the Thank","content":"<p>WASHINGTON (Reuters) - U.S. airlines and airports braced for a surge of travelers ahead of the Thanksgiving holiday, hoping the weather forecast remains calm as millions more Americans will hit the roads or skies.</p>\n<p>The U.S. Transportation Security Administration said Friday was the single busiest air travel day since the start of the COVID-19 pandemic in March 2020, as it screened 2.24 million travelers.</p>\n<p>TSA expects to screen about 20 million air passengers during the busy Thanksgiving travel period, compared with nearly 26 million in the same period in 2019.</p>\n<p>\"We are ready,\" TSA Administrator David Pekoske told reporters on Friday at Washington Reagan National Airport. \"We will be able to handle the passenger volumes that we anticipate seeing.\"</p>\n<p>As vaccination rates have risen, many Americans are traveling for the holidays after skipping family gatherings last November and December.</p>\n<p>Travel group AAA forecasts 53.4 million people will travel for the Thanksgiving holiday, up 13% from 2020 with most travelers going by car. About 48.3 million Thanksgiving travelers are expected to go by car, up from 47.1 million last year, but still below 2019's 49.9 million.</p>\n<p>Car travelers will be facing gasoline prices hovering near the highest point since 2014, which will prompt some Americans not to make holiday trips.</p>\n<p>Patrick De Haan, head of petroleum analysis at GasBuddy, said some Americans \"are responding to the prices by slamming the car door shut and staying off the road.\"</p>\n<p>Airlines are ramping up staffing and offering bonuses and other incentives to employees facing the busy holiday travel season.</p>\n<p>Delta Air Lines said it expects to fly up to 5.6 million passengers from Friday through Nov. 30, nearly 300% over 2020's 2.2 million Delta passengers for the period but still below the 6.3 million passengers during the same period in 2019.</p>\n<p>United Airlines said it anticipates more than 4.5 million passengers during the Thanksgiving travel period - about 88% of 2019 volume.</p>\n<p>United Chief Executive Scott Kirby told Skift last week he had a lot of confidence in the airline's ability to fly its holiday schedule. \"We've left ourselves a margin of error,\" Kirby said.</p>\n<p>He warned problems can ripple and \"If you are not careful it can cascade into a meltdown.\"</p>\n<p>Some other airlines have in recent weeks seen weather issues result in hundreds of daily cancellations over several days.</p>\n<p>United said it was adding about 700 domestic flights for Thanksgiving week, and would fly 87% of its 2019 domestic schedule in November.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. airlines, airports brace for busy Thanksgiving travel week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. airlines, airports brace for busy Thanksgiving travel week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-22 19:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/u-airlines-airports-brace-busy-110516916.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>WASHINGTON (Reuters) - U.S. airlines and airports braced for a surge of travelers ahead of the Thanksgiving holiday, hoping the weather forecast remains calm as millions more Americans will hit the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/u-airlines-airports-brace-busy-110516916.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DAL":"达美航空","UAL":"联合大陆航空"},"source_url":"https://finance.yahoo.com/news/u-airlines-airports-brace-busy-110516916.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184820113","content_text":"WASHINGTON (Reuters) - U.S. airlines and airports braced for a surge of travelers ahead of the Thanksgiving holiday, hoping the weather forecast remains calm as millions more Americans will hit the roads or skies.\nThe U.S. Transportation Security Administration said Friday was the single busiest air travel day since the start of the COVID-19 pandemic in March 2020, as it screened 2.24 million travelers.\nTSA expects to screen about 20 million air passengers during the busy Thanksgiving travel period, compared with nearly 26 million in the same period in 2019.\n\"We are ready,\" TSA Administrator David Pekoske told reporters on Friday at Washington Reagan National Airport. \"We will be able to handle the passenger volumes that we anticipate seeing.\"\nAs vaccination rates have risen, many Americans are traveling for the holidays after skipping family gatherings last November and December.\nTravel group AAA forecasts 53.4 million people will travel for the Thanksgiving holiday, up 13% from 2020 with most travelers going by car. About 48.3 million Thanksgiving travelers are expected to go by car, up from 47.1 million last year, but still below 2019's 49.9 million.\nCar travelers will be facing gasoline prices hovering near the highest point since 2014, which will prompt some Americans not to make holiday trips.\nPatrick De Haan, head of petroleum analysis at GasBuddy, said some Americans \"are responding to the prices by slamming the car door shut and staying off the road.\"\nAirlines are ramping up staffing and offering bonuses and other incentives to employees facing the busy holiday travel season.\nDelta Air Lines said it expects to fly up to 5.6 million passengers from Friday through Nov. 30, nearly 300% over 2020's 2.2 million Delta passengers for the period but still below the 6.3 million passengers during the same period in 2019.\nUnited Airlines said it anticipates more than 4.5 million passengers during the Thanksgiving travel period - about 88% of 2019 volume.\nUnited Chief Executive Scott Kirby told Skift last week he had a lot of confidence in the airline's ability to fly its holiday schedule. \"We've left ourselves a margin of error,\" Kirby said.\nHe warned problems can ripple and \"If you are not careful it can cascade into a meltdown.\"\nSome other airlines have in recent weeks seen weather issues result in hundreds of daily cancellations over several days.\nUnited said it was adding about 700 domestic flights for Thanksgiving week, and would fly 87% of its 2019 domestic schedule in November.","news_type":1},"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":842241510,"gmtCreate":1636188404053,"gmtModify":1636188404212,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great !!!","listText":"Great !!!","text":"Great !!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/842241510","repostId":"1173813098","repostType":4,"isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":827298772,"gmtCreate":1634474471295,"gmtModify":1634477860019,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Apple Car, Apple Glass probably will come next.&nbsp;Apple will continue to dominate in different spaces for years to come. &nbsp;","listText":"Apple Car, Apple Glass probably will come next.&nbsp;Apple will continue to dominate in different spaces for years to come. &nbsp;","text":"Apple Car, Apple Glass probably will come next. Apple will continue to dominate in different spaces for years to come.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/827298772","repostId":"1163053361","repostType":4,"repost":{"id":"1163053361","pubTimestamp":1634310263,"share":"https://www.laohu8.com/m/news/1163053361?lang=&edition=full","pubTime":"2021-10-15 23:04","market":"us","language":"en","title":"Apple: International Opportunity Is Huge","url":"https://stock-news.laohu8.com/highlight/detail?id=1163053361","media":"Seeking Alpha","summary":"Summary\n\nApple is trading at lower multiples than its peers and the Nasdaq.\nApple is making huge str","content":"<p><b>Summary</b></p>\n<ul>\n <li>Apple is trading at lower multiples than its peers and the Nasdaq.</li>\n <li>Apple is making huge strides in the European as well as international markets.</li>\n <li>As iPhones sell, so will AirPods, Apple Watches, and Apple services such as Music and Arcade.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bdd5b8fd99a0523d96bf052afd8c1b37\" tg-width=\"1536\" tg-height=\"988\" width=\"100%\" height=\"auto\"><span>Nikada/iStock Unreleased via Getty Images</span></p>\n<p><b>Thesis</b></p>\n<p>Apple (AAPL) is the largest company in the world by market cap. While large-cap stocks like Apple are usually close to fair value, Apple makes a compelling case. Arguably the best investor of all time, Warren Buffet has invested over 40% of Berkshire Hathaway's (BRK.A)(BRK.B)&nbsp;portfolio in Apple stock. So I decided that there must be some value proposition here. After a throughout look, I came to the same conclusion as Warren Buffet. Apple stock is an excellent buy.</p>\n<p>Apple's potential on a global scale has not been adequately factored into the share price.</p>\n<p><b>Current Valuation</b></p>\n<p>To understand if something is undervalued, we first need to understand its current valuation. To do so, I will briefly compare it to some similar stocks in both PE and P/FCF.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e3ac38cd59cd1890bbbab0bc6c0dee9d\" tg-width=\"635\" tg-height=\"515\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>As you can see, Apple is valued at lower PE and P/FCF multiples than similar companies Microsoft (MSFT) and Alphabet (GOOGL). It is also trading at a lower PE ratio than the Nasdaq index (29.25).</p>\n<p>This establishes that Apple is not being valued at a premium to reflect the massive opportunity they have with international expansion.</p>\n<p><b>Apple In The US</b></p>\n<p>If you are like me and from America, it may seem like everyone that wants an iPhone has one. There is a good chance you are even reading this article on Apple's signature OLED screen.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9e50a9091d291ea4b8efb3d37d00ad68\" tg-width=\"640\" tg-height=\"357\" width=\"100%\" height=\"auto\"><span>Source: Statista</span></p>\n<p>Apple's market share in the US has been growing by low single-digit percentages since 2015 and currently has a US market share of just under 50% in 2021.</p>\n<p>I see no real reason that this will change significantly. Like I mentioned above, most people that want an iPhone already own one. When dealing with such a high market share, it is hard to grow, at least substantially.</p>\n<p>While I will not discuss this point in-depth, it is worth noting that in 2020, only about&nbsp;50% of their revenue came from iPhone, and there is considerable room to grow in their accessories and wearables, even in the US.</p>\n<p><b>The International Market</b></p>\n<p>This is where I see a massive opportunity for Apple. They are already on their way to growing their global market share.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/458c0f8e1a5cec6bdd874c1d7f9de7df\" tg-width=\"640\" tg-height=\"449\" width=\"100%\" height=\"auto\"><span>Source: Statcounter</span></p>\n<p>Over the last 5 years, AAPL's global market share has gone from the high teens/low twenties to over 25%. Apple is also close to overtaking Samsung as the worldwide market share leader, and at current rates, it appears the overtake will happen sometime in the next twelve months.</p>\n<p>The upward trend is seen again in Europe. Here is AAPL's European market share over the past 5 years.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/581ba5b6950f54cb812ad7a9d0e4960e\" tg-width=\"640\" tg-height=\"450\" width=\"100%\" height=\"auto\"><span>Source: Statcounter</span></p>\n<p>In this case, Apple just recently took over Samsung as the leading European smartphone vendor. With a population of around&nbsp;741 million people, nearly&nbsp;2x the population of the United States, taking the majority share of the smartphone market in Europe is huge.</p>\n<p><b>What does that mean?</b></p>\n<p>This is just the beginning, at least from a sales standpoint. Despite controlling the majority share in one of the largest continents, Apple only generated about 1/4 of its total revenue from Europe.</p>\n<p>One of the things that makes Apple such a strong company is that their iPhones are essentially a \"gateway product.\" Once you have an iPhone, you are compelled to purchase AirPods and an Apple Watch as physical accessories. Apple also offers iCloud photo storage, Apple Music, Apple TV, and Apple Arcade, to name a few.</p>\n<p>The proliferation of the iPhone on a global scale opens the door for Apple with its massive product line. Investors should look behind the numbers and realize the true scope of the opportunity that lies within growing iPhone sales.</p>\n<p><b>Conclusion</b></p>\n<p>Apple's relative undervaluation compared to competitors, as well as massive strides in international markets, makes it an appealing investment. As iPhone sales continue to grow, accessories will be quick to follow. Apple is past the stages where you will see 100% growth in a relatively short timeline. This is a stock that you buy and hold for years, and if you are smart, sell covered calls along the way.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple: International Opportunity Is Huge</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple: International Opportunity Is Huge\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-15 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4459836-apple-international-opportunity-is-huge><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nApple is trading at lower multiples than its peers and the Nasdaq.\nApple is making huge strides in the European as well as international markets.\nAs iPhones sell, so will AirPods, Apple ...</p>\n\n<a href=\"https://seekingalpha.com/article/4459836-apple-international-opportunity-is-huge\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4459836-apple-international-opportunity-is-huge","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163053361","content_text":"Summary\n\nApple is trading at lower multiples than its peers and the Nasdaq.\nApple is making huge strides in the European as well as international markets.\nAs iPhones sell, so will AirPods, Apple Watches, and Apple services such as Music and Arcade.\n\nNikada/iStock Unreleased via Getty Images\nThesis\nApple (AAPL) is the largest company in the world by market cap. While large-cap stocks like Apple are usually close to fair value, Apple makes a compelling case. Arguably the best investor of all time, Warren Buffet has invested over 40% of Berkshire Hathaway's (BRK.A)(BRK.B) portfolio in Apple stock. So I decided that there must be some value proposition here. After a throughout look, I came to the same conclusion as Warren Buffet. Apple stock is an excellent buy.\nApple's potential on a global scale has not been adequately factored into the share price.\nCurrent Valuation\nTo understand if something is undervalued, we first need to understand its current valuation. To do so, I will briefly compare it to some similar stocks in both PE and P/FCF.\nData by YCharts\nAs you can see, Apple is valued at lower PE and P/FCF multiples than similar companies Microsoft (MSFT) and Alphabet (GOOGL). It is also trading at a lower PE ratio than the Nasdaq index (29.25).\nThis establishes that Apple is not being valued at a premium to reflect the massive opportunity they have with international expansion.\nApple In The US\nIf you are like me and from America, it may seem like everyone that wants an iPhone has one. There is a good chance you are even reading this article on Apple's signature OLED screen.\nSource: Statista\nApple's market share in the US has been growing by low single-digit percentages since 2015 and currently has a US market share of just under 50% in 2021.\nI see no real reason that this will change significantly. Like I mentioned above, most people that want an iPhone already own one. When dealing with such a high market share, it is hard to grow, at least substantially.\nWhile I will not discuss this point in-depth, it is worth noting that in 2020, only about 50% of their revenue came from iPhone, and there is considerable room to grow in their accessories and wearables, even in the US.\nThe International Market\nThis is where I see a massive opportunity for Apple. They are already on their way to growing their global market share.\nSource: Statcounter\nOver the last 5 years, AAPL's global market share has gone from the high teens/low twenties to over 25%. Apple is also close to overtaking Samsung as the worldwide market share leader, and at current rates, it appears the overtake will happen sometime in the next twelve months.\nThe upward trend is seen again in Europe. Here is AAPL's European market share over the past 5 years.\nSource: Statcounter\nIn this case, Apple just recently took over Samsung as the leading European smartphone vendor. With a population of around 741 million people, nearly 2x the population of the United States, taking the majority share of the smartphone market in Europe is huge.\nWhat does that mean?\nThis is just the beginning, at least from a sales standpoint. Despite controlling the majority share in one of the largest continents, Apple only generated about 1/4 of its total revenue from Europe.\nOne of the things that makes Apple such a strong company is that their iPhones are essentially a \"gateway product.\" Once you have an iPhone, you are compelled to purchase AirPods and an Apple Watch as physical accessories. Apple also offers iCloud photo storage, Apple Music, Apple TV, and Apple Arcade, to name a few.\nThe proliferation of the iPhone on a global scale opens the door for Apple with its massive product line. Investors should look behind the numbers and realize the true scope of the opportunity that lies within growing iPhone sales.\nConclusion\nApple's relative undervaluation compared to competitors, as well as massive strides in international markets, makes it an appealing investment. As iPhone sales continue to grow, accessories will be quick to follow. Apple is past the stages where you will see 100% growth in a relatively short timeline. This is a stock that you buy and hold for years, and if you are smart, sell covered calls along the way.","news_type":1},"isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877276657,"gmtCreate":1637939216050,"gmtModify":1637939216121,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Will this nightmare ever end !!!","listText":"Will this nightmare ever end !!!","text":"Will this nightmare ever end !!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877276657","repostId":"1125886564","repostType":4,"repost":{"id":"1125886564","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637938179,"share":"https://www.laohu8.com/m/news/1125886564?lang=&edition=full","pubTime":"2021-11-26 22:49","market":"us","language":"en","title":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1125886564","media":"Tiger Newspress","summary":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech ","content":"<p>Vaccine&nbsp;stocks&nbsp;continued&nbsp;to&nbsp;rise&nbsp;in&nbsp;early&nbsp;trading,&nbsp;Moderna&nbsp;shares&nbsp;surged&nbsp;more&nbsp;than&nbsp;23%&nbsp;and&nbsp;BioNTech&nbsp;jumped&nbsp;nearly&nbsp;19%.<img src=\"https://static.tigerbbs.com/2e9f40662925ec57d0176cf5f1e36df4\" tg-width=\"876\" tg-height=\"613\" referrerpolicy=\"no-referrer\">Germany's BioNTech &nbsp;said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.</p>\n<p>\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-26 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine&nbsp;stocks&nbsp;continued&nbsp;to&nbsp;rise&nbsp;in&nbsp;early&nbsp;trading,&nbsp;Moderna&nbsp;shares&nbsp;surged&nbsp;more&nbsp;than&nbsp;23%&nbsp;and&nbsp;BioNTech&nbsp;jumped&nbsp;nearly&nbsp;19%.<img src=\"https://static.tigerbbs.com/2e9f40662925ec57d0176cf5f1e36df4\" tg-width=\"876\" tg-height=\"613\" referrerpolicy=\"no-referrer\">Germany's BioNTech &nbsp;said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.</p>\n<p>\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125886564","content_text":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech jumped nearly 19%.Germany's BioNTech  said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.\n\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861343292,"gmtCreate":1632462972116,"gmtModify":1632464255042,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/861343292","repostId":"2169694977","repostType":4,"repost":{"id":"2169694977","pubTimestamp":1632462360,"share":"https://www.laohu8.com/m/news/2169694977?lang=&edition=full","pubTime":"2021-09-24 13:46","market":"sg","language":"en","title":"Singapore factory output grows 11.2% in August; chip production recovers","url":"https://stock-news.laohu8.com/highlight/detail?id=2169694977","media":"The Straits Times","summary":"SINGAPORE - Singapore's factory growth eased in August, on the back of a drop in biomedical manufact","content":"<div>\n<p>SINGAPORE - Singapore's factory growth eased in August, on the back of a drop in biomedical manufacturing output, but still came in better than expected, according to data out on Friday (Sept 24).\n...</p>\n\n<a href=\"http://www.straitstimes.com/business/economy/singapore-factory-output-growth-slows-to-112-in-august-chip-production-recovers\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore factory output grows 11.2% in August; chip production recovers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore factory output grows 11.2% in August; chip production recovers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-24 13:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/business/economy/singapore-factory-output-growth-slows-to-112-in-august-chip-production-recovers><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SINGAPORE - Singapore's factory growth eased in August, on the back of a drop in biomedical manufacturing output, but still came in better than expected, according to data out on Friday (Sept 24).\n...</p>\n\n<a href=\"http://www.straitstimes.com/business/economy/singapore-factory-output-growth-slows-to-112-in-august-chip-production-recovers\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"http://www.straitstimes.com/business/economy/singapore-factory-output-growth-slows-to-112-in-august-chip-production-recovers","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169694977","content_text":"SINGAPORE - Singapore's factory growth eased in August, on the back of a drop in biomedical manufacturing output, but still came in better than expected, according to data out on Friday (Sept 24).\nManufacturing output expanded 11.2 per cent year-on-year last month, down from a revised 16.4 per cent increase in July, but marking a 10th straight month of growth.\nIt also beat the 8.2 per cent increase forecast  by analysts in a Bloomberg poll.\nExcluding biomedical manufacturing, output increased 13.6 per cent in August.\nThe key electronics sector saw output expand by 15.4 per cent. Apart from the computer peripherals and data storage segment, all segments recorded output growth.\nIn particular, the semiconductors segment grew 16.8 per cent, supported by demand from 5G markets, after eking out growth of just 1.4 per cent in July.\nOn a year-to-date basis, the electronics cluster grew 19.6 per cent compared with the same period in 2020.\nThe volatile biomedical manufacturing sector saw its output fall 0.6 per cent. While the medical technology segment rose 8.2 per cent on the back of higher export demand for medical devices, the pharmaceuticals segment declined 3.4 per cent due to a different mix of active pharmaceutical ingredients.\nOn a year-to-date basis, the biomedical manufacturing cluster still grew 9.8 per cent.\nAll other sectors posted year-on-year growth in August.\nThe transport engineering cluster saw expanded output of 23.5 per cent, with all segments recording growth.\nThe marine and offshore engineering segment rose 36.9 per cent, while the aerospace segment increased output by 22 per cent.\nThe Economic Development Board (EDB) said: \"The levels of activity in the shipyards and aerospace firms had increased from a low base last year when new orders were impacted by the weak global oil and gas market and international travel restrictions respectively amid the Covid-19 pandemic.\"\nCumulatively, the transport engineering cluster grew 4.7 per cent in the period lasting from January to August, compared with the same period last year.\nPrecision engineering output also grew, by 22.9 per cent in August. The cluster's growth was largely attributed to the machinery and systems segment, which grew 33.1 per cent with higher output of semiconductor and industrial process equipment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608834806,"gmtCreate":1638677115521,"gmtModify":1638677115594,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608834806","repostId":"1140678193","repostType":4,"isVote":1,"tweetType":1,"viewCount":107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":852605226,"gmtCreate":1635260100610,"gmtModify":1635260327651,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852605226","repostId":"1170503429","repostType":4,"repost":{"id":"1170503429","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635258785,"share":"https://www.laohu8.com/m/news/1170503429?lang=&edition=full","pubTime":"2021-10-26 22:33","market":"us","language":"en","title":"AEye shares soared more than 100% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1170503429","media":"Tiger Newspress","summary":"AEye shares soared more than 100% in morning trading.Roth Capital analyst Suji Desilva initiated cov","content":"<p>AEye shares soared more than 100% in morning trading.<img src=\"https://static.tigerbbs.com/6a813a217051651312ed9d194f2424d0\" tg-width=\"894\" tg-height=\"622\" width=\"100%\" height=\"auto\"><b>Roth Capital</b>&nbsp;analyst&nbsp;<b>Suji Desilva</b>&nbsp;initiated coverage of&nbsp;<b>AEye Inc</b>&nbsp;with a&nbsp;Buy rating and $15 price target.</p>\n<p>The analyst notes that AEye recently came public through a merger with special purpose acquisition company CF Finance Acquisition Corp. III that was announced in February 2021 and subsequently closed in August 2021.</p>\n<p>Desilva expects AEye's advanced iDAR platform to gain traction in higher-order L3/L4/L5 ADAS/AV auto models, emphasizing more sophisticated highway driving safety.</p>\n<p>Further, he believes a significant advantage of AEye's business model is using a high margin licensing/royalty-based revenue model with potential for gross margins of 80%-plus at scale.</p>\n<p>The analyst also thinks AEye has secured a Tier-1 automotive partnership with Continental affirming, in his view, the strength of the company's lidar technology platform.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEye shares soared more than 100% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEye shares soared more than 100% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 22:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AEye shares soared more than 100% in morning trading.<img src=\"https://static.tigerbbs.com/6a813a217051651312ed9d194f2424d0\" tg-width=\"894\" tg-height=\"622\" width=\"100%\" height=\"auto\"><b>Roth Capital</b>&nbsp;analyst&nbsp;<b>Suji Desilva</b>&nbsp;initiated coverage of&nbsp;<b>AEye Inc</b>&nbsp;with a&nbsp;Buy rating and $15 price target.</p>\n<p>The analyst notes that AEye recently came public through a merger with special purpose acquisition company CF Finance Acquisition Corp. III that was announced in February 2021 and subsequently closed in August 2021.</p>\n<p>Desilva expects AEye's advanced iDAR platform to gain traction in higher-order L3/L4/L5 ADAS/AV auto models, emphasizing more sophisticated highway driving safety.</p>\n<p>Further, he believes a significant advantage of AEye's business model is using a high margin licensing/royalty-based revenue model with potential for gross margins of 80%-plus at scale.</p>\n<p>The analyst also thinks AEye has secured a Tier-1 automotive partnership with Continental affirming, in his view, the strength of the company's lidar technology platform.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LIDR":"AEye, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170503429","content_text":"AEye shares soared more than 100% in morning trading.Roth Capital analyst Suji Desilva initiated coverage of AEye Inc with a Buy rating and $15 price target.\nThe analyst notes that AEye recently came public through a merger with special purpose acquisition company CF Finance Acquisition Corp. III that was announced in February 2021 and subsequently closed in August 2021.\nDesilva expects AEye's advanced iDAR platform to gain traction in higher-order L3/L4/L5 ADAS/AV auto models, emphasizing more sophisticated highway driving safety.\nFurther, he believes a significant advantage of AEye's business model is using a high margin licensing/royalty-based revenue model with potential for gross margins of 80%-plus at scale.\nThe analyst also thinks AEye has secured a Tier-1 automotive partnership with Continental affirming, in his view, the strength of the company's lidar technology platform.","news_type":1},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690343729,"gmtCreate":1639642161719,"gmtModify":1639642205735,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Really","listText":"Really","text":"Really","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690343729","repostId":"1127770254","repostType":4,"isVote":1,"tweetType":1,"viewCount":677,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604421493,"gmtCreate":1639440410708,"gmtModify":1639440410893,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604421493","repostId":"2191984334","repostType":4,"repost":{"id":"2191984334","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639435732,"share":"https://www.laohu8.com/m/news/2191984334?lang=&edition=full","pubTime":"2021-12-14 06:48","market":"us","language":"en","title":"Wall Street ends down; investors eye Omicron and Fed meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2191984334","media":"Reuters","summary":"* Pfizer to buy Arena Pharma, shares of both companies rise\n* Meme stocks GameStop, AMC slump to mul","content":"<p>* Pfizer to buy Arena Pharma, shares of both companies rise</p>\n<p>*&nbsp;Meme stocks GameStop, AMC slump to multi-month lows</p>\n<p>* Consumer discretionary, energy lead declines</p>\n<p>Dec 13 (Reuters) - Wall Street ended lower on Monday, with shares of Carnival Corp and several airlines tumbling as investors worried about the Omicron coronavirus variant ahead of a Federal Reserve meeting later this week.</p>\n<p>Travel-related stocks fell, with the fast-spreading variant accounting for around 40% of COVID-19 infections in London and at least one death in the United Kingdom.</p>\n<p>Norwegian Cruise Line Holdings, Carnival Corp&nbsp;and Royal Caribbean Cruises&nbsp;all slumped more than 4%, while the S&amp;P 1500 airlines index&nbsp;shed about 3%.</p>\n<p>\"It's transportation, restaurants, all the things that if it got bad enough that we started putting new restrictions on people, it would not be good for them,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They have all been bid over the past several months by the idea that we were going to get back to business as usual.\"</p>\n<p>Most of the 11 major S&amp;P 500 sector indexes fell, with only defensive sectors, including consumer staples, utilities&nbsp;and real estate&nbsp;gaining.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 0.89% to end at 35,650.95 points, while the S&amp;P 500&nbsp;lost 0.91% to 4,668.97.</p>\n<p>The Nasdaq Composite&nbsp;dropped 1.39% to 15,413.28.</p>\n<p>Following Monday's dip, the S&amp;P 500 remains up about 24% year to date.</p>\n<p>Apple Inc&nbsp;dipped 2.1%, even after J.P. Morgan raised its price target on the iPhone maker to the highest on Wall Street. The company is close to becoming the first in the world to hit $3 trillion in market value.</p>\n<p>Investors expect an increasingly hawkish tone out of the Federal Reserve's two-day meeting that wraps up on Wednesday. The U.S. central bank is expected to signal a faster wind-down of asset purchases, which could also usher closer a start to interest rate hikes.</p>\n<p>\"Everyone is focused on the Fed this week and what guidance we get in terms of bond purchases and interest rates. There's an expectation that there will be an acceleration of tapering, and there's a little anxiety leading up to that,\" said Ryan Jacob, chief portfolio manager at Jacob Internet Fund.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p>Positive updates about vaccines and antibody cocktails to combat the new COVID-19 variant, along with a recent reading on inflation that was in line with consensus, pushed the S&amp;P 500&nbsp;index to a record closing high on Friday.</p>\n<p>Pfizer Inc&nbsp;rose 4.6% after it agreed to acquire Arena Pharmaceuticals&nbsp;in a $6.7 billion all-cash deal. Arena's shares surged 80%.</p>\n<p>Shares of Gamestop&nbsp;and AMC Entertainment&nbsp;tumbled to multi-month lows on Monday as some investors appeared to sour on the names that had produced eye-watering gains earlier in the year.</p>\n<p>Video game retailer GameStop tumbled 13.9% at $136.88, briefly touching its lowest level since April, while movie theater operator AMC slumped 15.3% to $23.24, a level last seen in May.</p>\n<p>Volume on U.S. exchanges was 10.4 billion shares, compared with the 11.4 billion average over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.30-to-1 ratio; on Nasdaq, a 2.53-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 33 new highs and 302 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down; investors eye Omicron and Fed meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down; investors eye Omicron and Fed meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-14 06:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Pfizer to buy Arena Pharma, shares of both companies rise</p>\n<p>*&nbsp;Meme stocks GameStop, AMC slump to multi-month lows</p>\n<p>* Consumer discretionary, energy lead declines</p>\n<p>Dec 13 (Reuters) - Wall Street ended lower on Monday, with shares of Carnival Corp and several airlines tumbling as investors worried about the Omicron coronavirus variant ahead of a Federal Reserve meeting later this week.</p>\n<p>Travel-related stocks fell, with the fast-spreading variant accounting for around 40% of COVID-19 infections in London and at least one death in the United Kingdom.</p>\n<p>Norwegian Cruise Line Holdings, Carnival Corp&nbsp;and Royal Caribbean Cruises&nbsp;all slumped more than 4%, while the S&amp;P 1500 airlines index&nbsp;shed about 3%.</p>\n<p>\"It's transportation, restaurants, all the things that if it got bad enough that we started putting new restrictions on people, it would not be good for them,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They have all been bid over the past several months by the idea that we were going to get back to business as usual.\"</p>\n<p>Most of the 11 major S&amp;P 500 sector indexes fell, with only defensive sectors, including consumer staples, utilities&nbsp;and real estate&nbsp;gaining.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 0.89% to end at 35,650.95 points, while the S&amp;P 500&nbsp;lost 0.91% to 4,668.97.</p>\n<p>The Nasdaq Composite&nbsp;dropped 1.39% to 15,413.28.</p>\n<p>Following Monday's dip, the S&amp;P 500 remains up about 24% year to date.</p>\n<p>Apple Inc&nbsp;dipped 2.1%, even after J.P. Morgan raised its price target on the iPhone maker to the highest on Wall Street. The company is close to becoming the first in the world to hit $3 trillion in market value.</p>\n<p>Investors expect an increasingly hawkish tone out of the Federal Reserve's two-day meeting that wraps up on Wednesday. The U.S. central bank is expected to signal a faster wind-down of asset purchases, which could also usher closer a start to interest rate hikes.</p>\n<p>\"Everyone is focused on the Fed this week and what guidance we get in terms of bond purchases and interest rates. There's an expectation that there will be an acceleration of tapering, and there's a little anxiety leading up to that,\" said Ryan Jacob, chief portfolio manager at Jacob Internet Fund.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p>Positive updates about vaccines and antibody cocktails to combat the new COVID-19 variant, along with a recent reading on inflation that was in line with consensus, pushed the S&amp;P 500&nbsp;index to a record closing high on Friday.</p>\n<p>Pfizer Inc&nbsp;rose 4.6% after it agreed to acquire Arena Pharmaceuticals&nbsp;in a $6.7 billion all-cash deal. Arena's shares surged 80%.</p>\n<p>Shares of Gamestop&nbsp;and AMC Entertainment&nbsp;tumbled to multi-month lows on Monday as some investors appeared to sour on the names that had produced eye-watering gains earlier in the year.</p>\n<p>Video game retailer GameStop tumbled 13.9% at $136.88, briefly touching its lowest level since April, while movie theater operator AMC slumped 15.3% to $23.24, a level last seen in May.</p>\n<p>Volume on U.S. exchanges was 10.4 billion shares, compared with the 11.4 billion average over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.30-to-1 ratio; on Nasdaq, a 2.53-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 33 new highs and 302 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CCL":"嘉年华邮轮","SQQQ":"纳指三倍做空ETF","BK4517":"邮轮概念","QID":"纳指两倍做空ETF","ARNA":"阿里那","BK4142":"酒店、度假村与豪华游轮","DDM":"道指两倍做多ETF","PSQ":"纳指反向ETF","UDOW":"道指三倍做多ETF-ProShares","DOG":"道指反向ETF","PFE":"辉瑞","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","DXD":"道指两倍做空ETF","BK4139":"生物科技","TQQQ":"纳指三倍做多ETF","NCLH":"挪威邮轮","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","BK4566":"资本集团","SDOW":"道指三倍做空ETF-ProShares","BK4568":"美国抗疫概念","RCL":"皇家加勒比邮轮","DJX":"1/100道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191984334","content_text":"* Pfizer to buy Arena Pharma, shares of both companies rise\n* Meme stocks GameStop, AMC slump to multi-month lows\n* Consumer discretionary, energy lead declines\nDec 13 (Reuters) - Wall Street ended lower on Monday, with shares of Carnival Corp and several airlines tumbling as investors worried about the Omicron coronavirus variant ahead of a Federal Reserve meeting later this week.\nTravel-related stocks fell, with the fast-spreading variant accounting for around 40% of COVID-19 infections in London and at least one death in the United Kingdom.\nNorwegian Cruise Line Holdings, Carnival Corp and Royal Caribbean Cruises all slumped more than 4%, while the S&P 1500 airlines index shed about 3%.\n\"It's transportation, restaurants, all the things that if it got bad enough that we started putting new restrictions on people, it would not be good for them,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They have all been bid over the past several months by the idea that we were going to get back to business as usual.\"\nMost of the 11 major S&P 500 sector indexes fell, with only defensive sectors, including consumer staples, utilities and real estate gaining.\nThe Dow Jones Industrial Average fell 0.89% to end at 35,650.95 points, while the S&P 500 lost 0.91% to 4,668.97.\nThe Nasdaq Composite dropped 1.39% to 15,413.28.\nFollowing Monday's dip, the S&P 500 remains up about 24% year to date.\nApple Inc dipped 2.1%, even after J.P. Morgan raised its price target on the iPhone maker to the highest on Wall Street. The company is close to becoming the first in the world to hit $3 trillion in market value.\nInvestors expect an increasingly hawkish tone out of the Federal Reserve's two-day meeting that wraps up on Wednesday. The U.S. central bank is expected to signal a faster wind-down of asset purchases, which could also usher closer a start to interest rate hikes.\n\"Everyone is focused on the Fed this week and what guidance we get in terms of bond purchases and interest rates. There's an expectation that there will be an acceleration of tapering, and there's a little anxiety leading up to that,\" said Ryan Jacob, chief portfolio manager at Jacob Internet Fund.\nA Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.\nPositive updates about vaccines and antibody cocktails to combat the new COVID-19 variant, along with a recent reading on inflation that was in line with consensus, pushed the S&P 500 index to a record closing high on Friday.\nPfizer Inc rose 4.6% after it agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal. Arena's shares surged 80%.\nShares of Gamestop and AMC Entertainment tumbled to multi-month lows on Monday as some investors appeared to sour on the names that had produced eye-watering gains earlier in the year.\nVideo game retailer GameStop tumbled 13.9% at $136.88, briefly touching its lowest level since April, while movie theater operator AMC slumped 15.3% to $23.24, a level last seen in May.\nVolume on U.S. exchanges was 10.4 billion shares, compared with the 11.4 billion average over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.30-to-1 ratio; on Nasdaq, a 2.53-to-1 ratio favored decliners.\nThe S&P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 33 new highs and 302 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":705,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602300738,"gmtCreate":1638966528449,"gmtModify":1638966528566,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602300738","repostId":"1177589023","repostType":4,"repost":{"id":"1177589023","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638964838,"share":"https://www.laohu8.com/m/news/1177589023?lang=&edition=full","pubTime":"2021-12-08 20:00","market":"us","language":"en","title":"Pfizer, BioNTech say third dose neutralizes Omicron variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1177589023","media":"Tiger Newspress","summary":"Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on ","content":"<p>Pfizer and biontech stocks narrowed their losses&nbsp;in premarket trading&nbsp;after&nbsp;they provided update on Omicron variant.</p>\n<p><img src=\"https://static.tigerbbs.com/896ce4e657b0942d9d7a0abce1c3d2f7\" tg-width=\"853\" tg-height=\"622\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/35c4bf42aa2936640aedd52e01beebc5\" tg-width=\"853\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><i>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers</i></li>\n <li><i>Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection</i></li>\n <li><i>As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease</i></li>\n <li><i>The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022</i></li>\n</ul>\n<p>Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;today announced results from an initial&nbsp;<i>laboratory</i>&nbsp;study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.</p>\n<p>Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.</p>\n<p>A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.</p>\n<p>“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said&nbsp;<b>Albert Bourla, Chairman and Chief Executive Officer, Pfizer</b>. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”</p>\n<p>“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said&nbsp;<b>Ugur Sahin, M.D., CEO and Co-Founder of BioNTech</b>. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”</p>\n<p>While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta &amp; Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, BioNTech say third dose neutralizes Omicron variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, BioNTech say third dose neutralizes Omicron variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-08 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer and biontech stocks narrowed their losses&nbsp;in premarket trading&nbsp;after&nbsp;they provided update on Omicron variant.</p>\n<p><img src=\"https://static.tigerbbs.com/896ce4e657b0942d9d7a0abce1c3d2f7\" tg-width=\"853\" tg-height=\"622\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/35c4bf42aa2936640aedd52e01beebc5\" tg-width=\"853\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><i>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers</i></li>\n <li><i>Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection</i></li>\n <li><i>As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease</i></li>\n <li><i>The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022</i></li>\n</ul>\n<p>Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;today announced results from an initial&nbsp;<i>laboratory</i>&nbsp;study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.</p>\n<p>Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.</p>\n<p>A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.</p>\n<p>“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said&nbsp;<b>Albert Bourla, Chairman and Chief Executive Officer, Pfizer</b>. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”</p>\n<p>“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said&nbsp;<b>Ugur Sahin, M.D., CEO and Co-Founder of BioNTech</b>. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”</p>\n<p>While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta &amp; Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177589023","content_text":"Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on Omicron variant.\n\n\nPreliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers\nData indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection\nAs 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease\nThe companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022\n\nPfizer Inc. and BioNTech SE today announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.\nSera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.\nA more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.\n“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”\n“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said Ugur Sahin, M.D., CEO and Co-Founder of BioNTech. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”\nWhile these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta & Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.","news_type":1},"isVote":1,"tweetType":1,"viewCount":523,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602994187,"gmtCreate":1638953822873,"gmtModify":1638953823034,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602994187","repostId":"2189663242","repostType":4,"repost":{"id":"2189663242","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638953662,"share":"https://www.laohu8.com/m/news/2189663242?lang=&edition=full","pubTime":"2021-12-08 16:54","market":"us","language":"en","title":"Tesla sold 52,859 China-made vehicles in November -CPCA","url":"https://stock-news.laohu8.com/highlight/detail?id=2189663242","media":"Reuters","summary":"BEIJING, Dec 8 (Reuters) - U.S. electric vehicle maker Tesla Inc sold 52,859 China-made vehicles in ","content":"<p>BEIJING, Dec 8 (Reuters) - U.S. electric vehicle maker Tesla Inc&nbsp;sold 52,859 China-made vehicles in November, including 21,127 for export, the China Passenger Car Association (CPCA) said on Wednesday.</p>\n<p>Tesla, which is making Model 3 sedans and Model Y sport-utility vehicles in Shanghai, sold 54,391 China-made vehicles in October, including 40,666 that were exported.</p>\n<p>Chinese EV makers Nio Inc&nbsp;10,878 cars last month, a monthly record high, and Xpeng Inc&nbsp;delivered 15,613 vehicles. <a href=\"https://laohu8.com/S/VLKAF\">Volkswagen AG</a>&nbsp;said it sold over 14,000 ID. series EVs in China in November.</p>\n<p>CPCA said passenger car sales in November in China totalled 1.85 million, down 12.5% from a year earlier.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla sold 52,859 China-made vehicles in November -CPCA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla sold 52,859 China-made vehicles in November -CPCA\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-08 16:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, Dec 8 (Reuters) - U.S. electric vehicle maker Tesla Inc&nbsp;sold 52,859 China-made vehicles in November, including 21,127 for export, the China Passenger Car Association (CPCA) said on Wednesday.</p>\n<p>Tesla, which is making Model 3 sedans and Model Y sport-utility vehicles in Shanghai, sold 54,391 China-made vehicles in October, including 40,666 that were exported.</p>\n<p>Chinese EV makers Nio Inc&nbsp;10,878 cars last month, a monthly record high, and Xpeng Inc&nbsp;delivered 15,613 vehicles. <a href=\"https://laohu8.com/S/VLKAF\">Volkswagen AG</a>&nbsp;said it sold over 14,000 ID. series EVs in China in November.</p>\n<p>CPCA said passenger car sales in November in China totalled 1.85 million, down 12.5% from a year earlier.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK1588":"回港中概股","BK4099":"汽车制造商","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4139":"生物科技","BK4531":"中概回港概念","09868":"小鹏汽车-W","BK1587":"次新股","BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","LHDX":"Lucira Health, Inc.","TSLA":"特斯拉","BK4504":"桥水持仓","CGEM":"Cullinan Therapeutics","LABP":"Landos Biopharma, Inc.","BK4505":"高瓴资本持仓","BK4555":"新能源车","BK4526":"热门中概股","SANA":"Sana Biotechnology, Inc.","BK4532":"文艺复兴科技持仓","BK4509":"腾讯概念","BK4527":"明星科技股","BK4082":"医疗保健设备","APR":"Apria, Inc.","BK4196":"保健护理服务","BK4548":"巴美列捷福持仓","NIO":"蔚来","BK1539":"汽车股","BK1119":"汽车制造商","BK1575":"同股不同权","BK4007":"制药","BK4551":"寇图资本持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189663242","content_text":"BEIJING, Dec 8 (Reuters) - U.S. electric vehicle maker Tesla Inc sold 52,859 China-made vehicles in November, including 21,127 for export, the China Passenger Car Association (CPCA) said on Wednesday.\nTesla, which is making Model 3 sedans and Model Y sport-utility vehicles in Shanghai, sold 54,391 China-made vehicles in October, including 40,666 that were exported.\nChinese EV makers Nio Inc 10,878 cars last month, a monthly record high, and Xpeng Inc delivered 15,613 vehicles. Volkswagen AG said it sold over 14,000 ID. series EVs in China in November.\nCPCA said passenger car sales in November in China totalled 1.85 million, down 12.5% from a year earlier.","news_type":1},"isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876254955,"gmtCreate":1637324290184,"gmtModify":1637324290420,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876254955","repostId":"1156318428","repostType":4,"repost":{"id":"1156318428","pubTimestamp":1637324149,"share":"https://www.laohu8.com/m/news/1156318428?lang=&edition=full","pubTime":"2021-11-19 20:15","market":"us","language":"en","title":"20 Stocks Moving in Friday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1156318428","media":"Benzinga","summary":"Gainers\n\nMammoth Energy Services, Inc. rose 29.9% to $2.87 in pre-market trading after the company a","content":"<p><b>Gainers</b></p>\n<ul>\n <li><b>Mammoth Energy Services, Inc.</b>&nbsp;rose 29.9% to $2.87 in pre-market trading after the company announced a multi-year electric vehicle charging station engineering contract.</li>\n <li><b>Longeveron Inc.</b>&nbsp;rose 27.8% to $8.78 in pre-market trading after the FDA gave rare pediatric disease designation to the company’s treatment for infant heart condition.</li>\n <li><b>Gracell Biotechnologies Inc.</b>&nbsp;rose 26.8% to $11.39 in pre-market trading after the company said it was granted FDA orphan drug designation for its FastCAR-enabled dual-targeting CAR-T cell therapy candidate GC012F for the treatment of multiple myeloma.</li>\n <li><b>UWM Holdings Corporation</b>&nbsp;shares rose 26.8% to $7.00 in pre-market trading after the company announced plans to accelerate buyback in public market in lieu of previously announced secondary offering and concurrent stock repurchase.</li>\n <li><b>Aurora Innovation, Inc.</b>&nbsp;rose 21% to $12.10 in pre-market trading after gaining over 8% on Thursday.</li>\n <li><b>BioHiTech Global, Inc.</b>&nbsp;rose 20.4% to $1.24 in pre-market trading after the company posted a narrower quarterly loss.</li>\n <li><b>Intuit Inc.</b>&nbsp;rose 12.3% to $706.19 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong forecast for FY22.</li>\n <li><b>IonQ, Inc.</b>&nbsp;rose 7.8% to $30.14 in pre-market trading after declining around 10% on Thursday. IonQ recently reported Q3 results and raised FY21 bookings guidance.</li>\n <li><b>OrganiGram Holdings Inc.</b>&nbsp;shares rose 6.7% to $2.15 in pre-market trading after declining 9% on Thursday. Organigram is launching a new wellness brand - Monjour, which is offering high-quality, CBD-forward products.</li>\n <li><b>Tilray, Inc.</b>&nbsp;rose 5.5% to $11.50 in pre-market trading on report that Germany is set to legalize marijuana nationwide.</li>\n</ul>\n<p><b>Losers</b></p>\n<ul>\n <li><b>Connect Biopharma Holdings Limited</b>&nbsp;shares fell 33.1% to $8.10 in pre-market trading after reporting top-line results from global Phase 2 trial of CBP-201 in patients with moderate-to-severe atopic dermatitis.</li>\n <li><b>AquaBounty Technologies, Inc.</b>&nbsp;fell 28.2% to $2.24 in pre-market trading after the company priced the public secondary offering of 11.2 million shares of its common stock by certain selling stockholders at $2.10 per share.</li>\n <li><b>Flora Growth Corp.</b>&nbsp;fell 22.8% to $2.85 in pre-market trading after tumbling 13% on Thursday.</li>\n <li><b>Farfetch Limited</b>&nbsp;shares fell 22.4% to $35.39 in pre-market trading after the company reported worse-than-expected Q3 sales results.</li>\n <li><b>RedHill Biopharma Ltd.</b>&nbsp;shares fell 11.3% to $3.44 in pre-market trading after the company reported an offering of common stock.</li>\n <li><b>Ecovyst Inc.</b>&nbsp;fell 9.5% to $9.65 in pre-market trading after the company reported pricing of 8 million share secondary offering at $9.50 per share.</li>\n <li><b>Williams-Sonoma, Inc.</b>&nbsp;shares fell 8.7% to $200.01 in pre-market trading after the company reported Q3 earnings results.</li>\n <li><b>Workday, Inc.</b>&nbsp;fell 7.1% to $277.98 in pre-market trading. Workday posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion.</li>\n <li><b>Applied Materials, Inc.</b>&nbsp;shares fell 6.1% to $149.13 in pre-market trading after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 EPS and sales guidance below estimates.</li>\n <li><b>Ross Stores, Inc.</b>&nbsp;fell 4.3% to $114.41 in pre-market trading. Ross Stores reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>20 Stocks Moving in Friday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n20 Stocks Moving in Friday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-19 20:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/24189889/20-stocks-moving-in-fridays-pre-market-session><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nMammoth Energy Services, Inc. rose 29.9% to $2.87 in pre-market trading after the company announced a multi-year electric vehicle charging station engineering contract.\nLongeveron Inc. rose ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24189889/20-stocks-moving-in-fridays-pre-market-session\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc.","LGVN":"Longeveron Inc","UWMC":"UWM Holdings Corporation"},"source_url":"https://www.benzinga.com/news/21/11/24189889/20-stocks-moving-in-fridays-pre-market-session","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156318428","content_text":"Gainers\n\nMammoth Energy Services, Inc. rose 29.9% to $2.87 in pre-market trading after the company announced a multi-year electric vehicle charging station engineering contract.\nLongeveron Inc. rose 27.8% to $8.78 in pre-market trading after the FDA gave rare pediatric disease designation to the company’s treatment for infant heart condition.\nGracell Biotechnologies Inc. rose 26.8% to $11.39 in pre-market trading after the company said it was granted FDA orphan drug designation for its FastCAR-enabled dual-targeting CAR-T cell therapy candidate GC012F for the treatment of multiple myeloma.\nUWM Holdings Corporation shares rose 26.8% to $7.00 in pre-market trading after the company announced plans to accelerate buyback in public market in lieu of previously announced secondary offering and concurrent stock repurchase.\nAurora Innovation, Inc. rose 21% to $12.10 in pre-market trading after gaining over 8% on Thursday.\nBioHiTech Global, Inc. rose 20.4% to $1.24 in pre-market trading after the company posted a narrower quarterly loss.\nIntuit Inc. rose 12.3% to $706.19 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong forecast for FY22.\nIonQ, Inc. rose 7.8% to $30.14 in pre-market trading after declining around 10% on Thursday. IonQ recently reported Q3 results and raised FY21 bookings guidance.\nOrganiGram Holdings Inc. shares rose 6.7% to $2.15 in pre-market trading after declining 9% on Thursday. Organigram is launching a new wellness brand - Monjour, which is offering high-quality, CBD-forward products.\nTilray, Inc. rose 5.5% to $11.50 in pre-market trading on report that Germany is set to legalize marijuana nationwide.\n\nLosers\n\nConnect Biopharma Holdings Limited shares fell 33.1% to $8.10 in pre-market trading after reporting top-line results from global Phase 2 trial of CBP-201 in patients with moderate-to-severe atopic dermatitis.\nAquaBounty Technologies, Inc. fell 28.2% to $2.24 in pre-market trading after the company priced the public secondary offering of 11.2 million shares of its common stock by certain selling stockholders at $2.10 per share.\nFlora Growth Corp. fell 22.8% to $2.85 in pre-market trading after tumbling 13% on Thursday.\nFarfetch Limited shares fell 22.4% to $35.39 in pre-market trading after the company reported worse-than-expected Q3 sales results.\nRedHill Biopharma Ltd. shares fell 11.3% to $3.44 in pre-market trading after the company reported an offering of common stock.\nEcovyst Inc. fell 9.5% to $9.65 in pre-market trading after the company reported pricing of 8 million share secondary offering at $9.50 per share.\nWilliams-Sonoma, Inc. shares fell 8.7% to $200.01 in pre-market trading after the company reported Q3 earnings results.\nWorkday, Inc. fell 7.1% to $277.98 in pre-market trading. Workday posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion.\nApplied Materials, Inc. shares fell 6.1% to $149.13 in pre-market trading after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 EPS and sales guidance below estimates.\nRoss Stores, Inc. fell 4.3% to $114.41 in pre-market trading. Ross Stores reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter.","news_type":1},"isVote":1,"tweetType":1,"viewCount":56,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871622999,"gmtCreate":1637066821163,"gmtModify":1637066821317,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Really","listText":"Really","text":"Really","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871622999","repostId":"1115914926","repostType":4,"repost":{"id":"1115914926","pubTimestamp":1637065849,"share":"https://www.laohu8.com/m/news/1115914926?lang=&edition=full","pubTime":"2021-11-16 20:30","market":"us","language":"en","title":"Report says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1115914926","media":"Reuters","summary":"Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justifi","content":"<p>Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S. group that reviews the value of medicines said on Tuesday.</p>\n<p>AbbVie Inc's(ABBV.N)widely used Humira rheumatoid arthritis drug accounted for the majority of the spending increase, with a net price increase of 9.6% leading to an almost $1.4 billion increase in U.S. spending.</p>\n<p>The Boston-based Institute for Clinical and Economic Review (ICER) said in a report that after reviewing published studies and input from drug manufacturers it found no evidence of new clinical benefits to justify the price hikes.</p>\n<p>\"Several of these treatments have been on the market for many years, with scant evidence that they are any more effective than we understood them to be years ago when they cost far less,\" said ICER Chief Medical Officer David Rind.</p>\n<p>\"The most extreme of these is Humira, with an ever-escalating U.S. price that contrasts starkly to its falling price in every country where Humira currently faces biosimilar competition,\" he said in a statement. Humira received U.S. regulatory approval in 2002.</p>\n<p>AbbVie said in a response to ICER that the report lacked context because ICER does not perform full value assessments and excludes evidence from smaller patient populations.</p>\n<p>The findings come as President Joe Biden and Democrats in Congress attempt to push through legislation that would lower drug prices by allowing the federal government to negotiate drug payments by Medicare, which covers Americans aged 65 and older.</p>\n<p>The United States spends more than twice as much per person on drugs as other wealthy economies, about $1,500, for a total of around $350 billion in 2019.</p>\n<p>Novartis(NOVN.S)drug Promacta, which is used to treat the rare blood disorder severe aplastic anemia (SAA), saw the highest increase in net price at 14.1%, leading to a $100 million increase in U.S. spending.</p>\n<p>Novartis said it takes a value-based pricing approach and that it provided ICER with significant new clinical and health economic data that the group did not take into account.</p>","source":"lsy1601381805984","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Report says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReport says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-16 20:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/business/healthcare-pharmaceuticals/report-says-drugmakers-impose-unjustified-us-price-increases-spending-abbvie-2021-11-16/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S. group that reviews the value of medicines ...</p>\n\n<a href=\"https://www.reuters.com/business/healthcare-pharmaceuticals/report-says-drugmakers-impose-unjustified-us-price-increases-spending-abbvie-2021-11-16/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司"},"source_url":"https://www.reuters.com/business/healthcare-pharmaceuticals/report-says-drugmakers-impose-unjustified-us-price-increases-spending-abbvie-2021-11-16/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115914926","content_text":"Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S. group that reviews the value of medicines said on Tuesday.\nAbbVie Inc's(ABBV.N)widely used Humira rheumatoid arthritis drug accounted for the majority of the spending increase, with a net price increase of 9.6% leading to an almost $1.4 billion increase in U.S. spending.\nThe Boston-based Institute for Clinical and Economic Review (ICER) said in a report that after reviewing published studies and input from drug manufacturers it found no evidence of new clinical benefits to justify the price hikes.\n\"Several of these treatments have been on the market for many years, with scant evidence that they are any more effective than we understood them to be years ago when they cost far less,\" said ICER Chief Medical Officer David Rind.\n\"The most extreme of these is Humira, with an ever-escalating U.S. price that contrasts starkly to its falling price in every country where Humira currently faces biosimilar competition,\" he said in a statement. Humira received U.S. regulatory approval in 2002.\nAbbVie said in a response to ICER that the report lacked context because ICER does not perform full value assessments and excludes evidence from smaller patient populations.\nThe findings come as President Joe Biden and Democrats in Congress attempt to push through legislation that would lower drug prices by allowing the federal government to negotiate drug payments by Medicare, which covers Americans aged 65 and older.\nThe United States spends more than twice as much per person on drugs as other wealthy economies, about $1,500, for a total of around $350 billion in 2019.\nNovartis(NOVN.S)drug Promacta, which is used to treat the rare blood disorder severe aplastic anemia (SAA), saw the highest increase in net price at 14.1%, leading to a $100 million increase in U.S. spending.\nNovartis said it takes a value-based pricing approach and that it provided ICER with significant new clinical and health economic data that the group did not take into account.","news_type":1},"isVote":1,"tweetType":1,"viewCount":28,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821762846,"gmtCreate":1633792636588,"gmtModify":1633792641442,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/821762846","repostId":"2174921131","repostType":4,"isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604279292,"gmtCreate":1639407389820,"gmtModify":1639407390372,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604279292","repostId":"1133455327","repostType":4,"repost":{"id":"1133455327","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406792,"share":"https://www.laohu8.com/m/news/1133455327?lang=&edition=full","pubTime":"2021-12-13 22:46","market":"us","language":"en","title":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133455327","media":"Tiger Newspress","summary":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping ove","content":"<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133455327","content_text":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.\nA new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.","news_type":1},"isVote":1,"tweetType":1,"viewCount":571,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609633796,"gmtCreate":1638276474074,"gmtModify":1638276474139,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609633796","repostId":"1183198352","repostType":4,"isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877092107,"gmtCreate":1637836540767,"gmtModify":1637836540832,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877092107","repostId":"1182200011","repostType":4,"repost":{"id":"1182200011","pubTimestamp":1637831082,"share":"https://www.laohu8.com/m/news/1182200011?lang=&edition=full","pubTime":"2021-11-25 17:04","market":"us","language":"en","title":"The Market Believes the Fed Will Have to Raise Rates Soon. What It Means for Stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=1182200011","media":"Barrons","summary":"Fixed-income markets are signaling that the Federal Reserve will have to increase interest rates soo","content":"<p>Fixed-income markets are signaling that the Federal Reserve will have to increase interest rates sooner than expected, which could put a dent in the stock market.</p>\n<p>The yield on the 2-year Treasury note has gone from 0.5% in early November to 0.64% as of Wednesday. The move suggests that investors expect the Fed to raise interest rates to combat inflation that remains higher than expected because of soaring consumer demand and supply chains that struggling to match demand.</p>\n<p>Indeed, minutes released Wednesday from the Fed’s meeting earlier this month show that members of the central bank are prepared to increase rates sooner than previously anticipated if inflation remains high.</p>\n<p>That belief is beginning to creep into credit spreads between corporate and government debt. A Bank of America index of investment-grade corporate bonds shows that, in aggregate, the spread over Treasury yields has increased to 0.94% from 0.89% earlier this month as investors have fled corporate bonds in anticipation of rate increases that could slow economic growth and pressure profits.</p>\n<p>Consistent with that, credit spreads for investment-grade corporate bonds in more economically sensitive sectors are rising against government debt. Ten-year bonds issues by manufacturing companies in the S&amp;P 500 yield 1.08 percentage points more than the 10-year Treasury note, according to FactSet, an increase from the 0.99 percentage point spread seen at the lowest levels of November. The spread for corporate bonds in the energy sector has risen to 1.41 percentage points from a November low of 1.2.</p>\n<p>“The market expects one to two [rate] hikes next year and that’s why you’re seeing credit spreads increase,” said John Ham, wealth advisor at New England Investments &amp; Retirement Group, told Barron’s Wednesday.</p>\n<p>Although the major indexes are off their all-time highs, this sentiment hasn’t caused a selloff of more than 5%. The S&amp;P 500, Nasdaq Composite, and Dow Jones Industrial Average are down 0.1%, 1.3%, and 1.7% from their highs.</p>\n<p>But the pain could come if credit spreads continue to widen. “Eventually that’s going to creep back into the equity market,” Harvey said.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Market Believes the Fed Will Have to Raise Rates Soon. What It Means for Stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Market Believes the Fed Will Have to Raise Rates Soon. What It Means for Stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-25 17:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/stock-market-fed-rate-increase-51637790713?mod=newsviewer_click_seemore><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Fixed-income markets are signaling that the Federal Reserve will have to increase interest rates sooner than expected, which could put a dent in the stock market.\nThe yield on the 2-year Treasury note...</p>\n\n<a href=\"https://www.marketwatch.com/articles/stock-market-fed-rate-increase-51637790713?mod=newsviewer_click_seemore\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/articles/stock-market-fed-rate-increase-51637790713?mod=newsviewer_click_seemore","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1182200011","content_text":"Fixed-income markets are signaling that the Federal Reserve will have to increase interest rates sooner than expected, which could put a dent in the stock market.\nThe yield on the 2-year Treasury note has gone from 0.5% in early November to 0.64% as of Wednesday. The move suggests that investors expect the Fed to raise interest rates to combat inflation that remains higher than expected because of soaring consumer demand and supply chains that struggling to match demand.\nIndeed, minutes released Wednesday from the Fed’s meeting earlier this month show that members of the central bank are prepared to increase rates sooner than previously anticipated if inflation remains high.\nThat belief is beginning to creep into credit spreads between corporate and government debt. A Bank of America index of investment-grade corporate bonds shows that, in aggregate, the spread over Treasury yields has increased to 0.94% from 0.89% earlier this month as investors have fled corporate bonds in anticipation of rate increases that could slow economic growth and pressure profits.\nConsistent with that, credit spreads for investment-grade corporate bonds in more economically sensitive sectors are rising against government debt. Ten-year bonds issues by manufacturing companies in the S&P 500 yield 1.08 percentage points more than the 10-year Treasury note, according to FactSet, an increase from the 0.99 percentage point spread seen at the lowest levels of November. The spread for corporate bonds in the energy sector has risen to 1.41 percentage points from a November low of 1.2.\n“The market expects one to two [rate] hikes next year and that’s why you’re seeing credit spreads increase,” said John Ham, wealth advisor at New England Investments & Retirement Group, told Barron’s Wednesday.\nAlthough the major indexes are off their all-time highs, this sentiment hasn’t caused a selloff of more than 5%. The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average are down 0.1%, 1.3%, and 1.7% from their highs.\nBut the pain could come if credit spreads continue to widen. “Eventually that’s going to creep back into the equity market,” Harvey said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875032878,"gmtCreate":1637586110815,"gmtModify":1637586110879,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875032878","repostId":"1118935265","repostType":4,"repost":{"id":"1118935265","pubTimestamp":1637585570,"share":"https://www.laohu8.com/m/news/1118935265?lang=&edition=full","pubTime":"2021-11-22 20:52","market":"us","language":"en","title":"GlobalFoundries Shares Pop As Analysts Initiate Coverage; See Up To 61% Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1118935265","media":"Benzinga","summary":"Multiple analysts initiated coverage on GLOBALFOUNDRIES Inc.\nCredit Suisse analyst John Pitzer initi","content":"<ul>\n <li>Multiple&nbsp;analysts initiated coverage&nbsp;on&nbsp;<b>GLOBALFOUNDRIES Inc</b>.</li>\n <li><b>Credit Suisse</b>&nbsp;analyst John Pitzer initiated coverage with an Outperform and $75 price target, implying a 20.8% upside.</li>\n <li>The analyst says the benefits of the company's 2018 strategic pivot from \"bleeding edge\" to \"pervasive\" are just now inflecting.</li>\n <li>He sees semi-cyclical and foundry secular tailwinds for GlobalFoundries.</li>\n <li><b>Citi</b>&nbsp;analyst Christopher Danely initiated coverage with a Buy rating and $75 price target.</li>\n <li>The analyst expects the company to experience the most significant margin and earnings expansion in the semiconductor group, with gross margin expanding from 14% in 2021 to 30% in 2023, driven by higher pricing and restructuring initiatives.</li>\n <li><b>Needham</b>&nbsp;analyst Rajvindra Gill initiated coverage with a Buy and a price target of $85, implying a 36.9% upside.</li>\n <li><b>JP Morgan</b>&nbsp;analyst Harlan Sur initiated coverage with an Overweight and a price target of $80, implying a 28.8% upside.</li>\n <li><b>Cowen</b>&nbsp;analyst Krish Sankar initiated coverage with an Outperform and $80 price.</li>\n <li><b>Raymond James</b>&nbsp;analyst Chris Caso initiated coverage with an Outperform and $80 price target.</li>\n <li><b>Jefferies</b>&nbsp;analyst Mark Lipacis initiated coverage with a Buy rating and a price target of $87, implying a 40.1% upside.</li>\n <li><b>Baird</b>&nbsp;analyst Tristan Gerra initiated coverage with an Outperform and a $100 price target, implying a 61% upside.</li>\n <li><b>Price Action:</b>&nbsp;GFS shares traded higher by 5.46% at $65.5 in the premarket session on the last check Monday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GlobalFoundries Shares Pop As Analysts Initiate Coverage; See Up To 61% Upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGlobalFoundries Shares Pop As Analysts Initiate Coverage; See Up To 61% Upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-22 20:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/24217002/globalfoundries-shares-pop-as-analysts-initiate-coverage-see-up-to-61-upside><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Multiple analysts initiated coverage on GLOBALFOUNDRIES Inc.\nCredit Suisse analyst John Pitzer initiated coverage with an Outperform and $75 price target, implying a 20.8% upside.\nThe analyst says the...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24217002/globalfoundries-shares-pop-as-analysts-initiate-coverage-see-up-to-61-upside\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GFS":"GLOBALFOUNDRIES Inc."},"source_url":"https://www.benzinga.com/news/21/11/24217002/globalfoundries-shares-pop-as-analysts-initiate-coverage-see-up-to-61-upside","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118935265","content_text":"Multiple analysts initiated coverage on GLOBALFOUNDRIES Inc.\nCredit Suisse analyst John Pitzer initiated coverage with an Outperform and $75 price target, implying a 20.8% upside.\nThe analyst says the benefits of the company's 2018 strategic pivot from \"bleeding edge\" to \"pervasive\" are just now inflecting.\nHe sees semi-cyclical and foundry secular tailwinds for GlobalFoundries.\nCiti analyst Christopher Danely initiated coverage with a Buy rating and $75 price target.\nThe analyst expects the company to experience the most significant margin and earnings expansion in the semiconductor group, with gross margin expanding from 14% in 2021 to 30% in 2023, driven by higher pricing and restructuring initiatives.\nNeedham analyst Rajvindra Gill initiated coverage with a Buy and a price target of $85, implying a 36.9% upside.\nJP Morgan analyst Harlan Sur initiated coverage with an Overweight and a price target of $80, implying a 28.8% upside.\nCowen analyst Krish Sankar initiated coverage with an Outperform and $80 price.\nRaymond James analyst Chris Caso initiated coverage with an Outperform and $80 price target.\nJefferies analyst Mark Lipacis initiated coverage with a Buy rating and a price target of $87, implying a 40.1% upside.\nBaird analyst Tristan Gerra initiated coverage with an Outperform and a $100 price target, implying a 61% upside.\nPrice Action: GFS shares traded higher by 5.46% at $65.5 in the premarket session on the last check Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":7,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876000305,"gmtCreate":1637239794814,"gmtModify":1637239794873,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876000305","repostId":"2184602028","repostType":4,"repost":{"id":"2184602028","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1637239035,"share":"https://www.laohu8.com/m/news/2184602028?lang=&edition=full","pubTime":"2021-11-18 20:37","market":"us","language":"en","title":"Tesla recalls 7,600 U.S. vehicles for potential air bag issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2184602028","media":"Reuters","summary":"Nov 18 (Reuters) - Tesla is recalling 7,600 vehicles in the United States because the driver's air b","content":"<p>Nov 18 (Reuters) - Tesla is recalling 7,600 vehicles in the United States because the driver's air bag cushion may tear during deployment, the National Highway Traffic Safety Administration said Thursday.</p>\n<p>The recall covers some 2021 Model X and Model S vehicles, the auto safety agency said. Owner notification letters are expected to be mailed Jan. 7.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla recalls 7,600 U.S. vehicles for potential air bag issue</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla recalls 7,600 U.S. vehicles for potential air bag issue\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-18 20:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nov 18 (Reuters) - Tesla is recalling 7,600 vehicles in the United States because the driver's air bag cushion may tear during deployment, the National Highway Traffic Safety Administration said Thursday.</p>\n<p>The recall covers some 2021 Model X and Model S vehicles, the auto safety agency said. Owner notification letters are expected to be mailed Jan. 7.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4099":"汽车制造商","BK4550":"红杉资本持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","TSLA":"特斯拉","BK4527":"明星科技股","BK4534":"瑞士信贷持仓","BK4555":"新能源车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2184602028","content_text":"Nov 18 (Reuters) - Tesla is recalling 7,600 vehicles in the United States because the driver's air bag cushion may tear during deployment, the National Highway Traffic Safety Administration said Thursday.\nThe recall covers some 2021 Model X and Model S vehicles, the auto safety agency said. Owner notification letters are expected to be mailed Jan. 7.","news_type":1},"isVote":1,"tweetType":1,"viewCount":61,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879952103,"gmtCreate":1636678559705,"gmtModify":1636678559871,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879952103","repostId":"1137718483","repostType":4,"repost":{"id":"1137718483","pubTimestamp":1636677707,"share":"https://www.laohu8.com/m/news/1137718483?lang=&edition=full","pubTime":"2021-11-12 08:41","market":"us","language":"en","title":"Why Wait for a Crash to Buy? These 3 Top Stocks Are Already Down More Than 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137718483","media":"Motley Fool","summary":"$Alibaba$ Group has plummeted 49% since peaking 13 months ago.Alibaba's Singles' Day isn't what it used to be now given China's \"common prosperity\" initiative.Alibaba and two other U.S. former market darlings have a strong chance to bounce back from here.Alibaba enters Singles' Day trading 49% below the all-time high it hit late last year. Investors have steered clear of China's growth stocks in the wake of the government's crackdown on several industries, but the real bargain for Singles' Day c","content":"<p>Key Points</p>\n<ul>\n <li><a href=\"https://laohu8.com/S/BABA\">Alibaba</a> Group has plummeted 49% since peaking 13 months ago.</li>\n <li>Alibaba's Singles' Day isn't what it used to be now given China's \"common prosperity\" initiative.</li>\n <li>Alibaba&nbsp;and two other U.S. former market darlings have a strong chance to bounce back from here.</li>\n</ul>\n<p>The market's getting volatile, but it's still trading close to its recent all-time highs. Are you waiting for the market to take a big hit before putting your money on the sidelines to work? Well, a lot of last year's biggest stars have already crashed.</p>\n<p>Shares of<b><a href=\"https://laohu8.com/S/09988\">Alibaba</a> Group Holding</b>(NYSE:BABA),<b><a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video</b>, and&nbsp;<a href=\"https://laohu8.com/S/PINS\"><b>Pinterest</b></a>&nbsp;have all plummeted at least 40% since hitting all-time highs. The markdowns seem overdone. Let's take a closer look.</p>\n<p>1. Alibaba</p>\n<p>Thursday should've been a big day for China's online retailers. It's Singles' Day! Alibaba created the shopping holiday that takes place every year on Nov. 11 -- called Singles' Day because of the 11/11 date -- but it has since been widely adopted by smaller e-tailers.</p>\n<p>Singles' Day is hitting different this year. China's government push for \"common prosperity\" finds it unfashionable to tout commerce and consumption. Alibaba is highly unlikely to match the $74 billion it rang up in sales during last year's \"Double 11\" celebration.</p>\n<p>Alibaba enters Singles' Day trading 49% below the all-time high it hit late last year. Investors have steered clear of China's growth stocks in the wake of the government's crackdown on several industries, but the real bargain for Singles' Day could be shares of Alibaba itself. It has grown revenue by at least 32% every year over the past decade. Even now as Alibaba grapples with the COVID-19 crisis and the country's common prosperity objectives, trailing revenue has climbed 40%.</p>\n<p>2. <a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video</p>\n<p>The rise and fall of Zoom Video is well known. The videoconferencing platform skyrocketed in popularity during the early months of the pandemic when in-person classes, work meetings, and gatherings of friends and family weren't safe. Now that we're largely vaccinated and case counts are lower is there really a future for Zoom?</p>\n<p>The market seems to think that the future will be bleak. Like Alibaba, shares of Zoom peaked 13 months ago. Zoom stock has plummeted 57% since that high. The twist here is that Zoom is still growing. Revenue rose 54% inits latest quarter. Sure, revenue is decelerating. We're not going to return to the triple-digit top-line growth that Zoom posted in each of the five previous quarterly reports.</p>\n<p>However, Zoom is still growing in the recovery climate. Video meetings will continue to be a cost-effective way to gather and get things done. Zoom is fleshing out its offerings, and a recently fumbled acquisition attempt won't stop the evolutionary process. There was a crazy time last year when Zoom was trading for more than 100 times trailing revenue. The one-two punch of heady sales growth and the cascading stock price finds that multiple whittled down to just 20 right now.</p>\n<p>3. Pinterest</p>\n<p>A year ago we were leaning on Pinterest to get crafty. The visual discovery engine was a valuable resource for recipes, decorating tips, and daydreaming about destinations we wanted to visit once we were able to safely travel after the pandemic.</p>\n<p>Everything was going swimmingly for Pinterest until we were cool to toss out our sourdough starter and head outside to eat someone else's bread. Pinterest has now stunned investors with back-to-back sequential declines in active users. The stock has plummeted 49% from February's peak.</p>\n<p>Last month&nbsp;<b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings</b>&nbsp;was reportedly negotiating to buy Pinterest in a largely stock deal that would value Pinterest at$70 a share. Pinterest investors who were cocky about holding out for more would love a chance to get back there, as the stock has fallen sharply since the proposed combination came undone. Pinterest would have to appreciate by 53% to get to $70 now.</p>\n<p>PayPal stock sold off on the initial chatter, but it continues to fall even now that a deal is not on the table. It probably won't come back on bended knee now that both stocks are out of favor, but Pinterest still has a vibrant platform with improving monetization. Revenue is still growing as advertisers flock its marketing opportunities to reach the lucrative Pinterest audience.</p>\n<p>Alibaba, Zoom, and Pinterest are still thrivinggrowth stocks. The shares just happen to be trading between 49% and 57% off their all-time highs. You don't need to wait for the market crash to happen to pick up bargains. They're out there now.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Wait for a Crash to Buy? These 3 Top Stocks Are Already Down More Than 40%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Wait for a Crash to Buy? These 3 Top Stocks Are Already Down More Than 40%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 08:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/11/why-wait-for-a-crash-to-buy-these-3-top-stocks-are/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nAlibaba Group has plummeted 49% since peaking 13 months ago.\nAlibaba's Singles' Day isn't what it used to be now given China's \"common prosperity\" initiative.\nAlibaba and two other U.S. ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/11/why-wait-for-a-crash-to-buy-these-3-top-stocks-are/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴","ZM":"Zoom","PINS":"Pinterest, Inc."},"source_url":"https://www.fool.com/investing/2021/11/11/why-wait-for-a-crash-to-buy-these-3-top-stocks-are/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137718483","content_text":"Key Points\n\nAlibaba Group has plummeted 49% since peaking 13 months ago.\nAlibaba's Singles' Day isn't what it used to be now given China's \"common prosperity\" initiative.\nAlibaba and two other U.S. former market darlings have a strong chance to bounce back from here.\n\nThe market's getting volatile, but it's still trading close to its recent all-time highs. Are you waiting for the market to take a big hit before putting your money on the sidelines to work? Well, a lot of last year's biggest stars have already crashed.\nShares ofAlibaba Group Holding(NYSE:BABA),Zoom Video, and Pinterest have all plummeted at least 40% since hitting all-time highs. The markdowns seem overdone. Let's take a closer look.\n1. Alibaba\nThursday should've been a big day for China's online retailers. It's Singles' Day! Alibaba created the shopping holiday that takes place every year on Nov. 11 -- called Singles' Day because of the 11/11 date -- but it has since been widely adopted by smaller e-tailers.\nSingles' Day is hitting different this year. China's government push for \"common prosperity\" finds it unfashionable to tout commerce and consumption. Alibaba is highly unlikely to match the $74 billion it rang up in sales during last year's \"Double 11\" celebration.\nAlibaba enters Singles' Day trading 49% below the all-time high it hit late last year. Investors have steered clear of China's growth stocks in the wake of the government's crackdown on several industries, but the real bargain for Singles' Day could be shares of Alibaba itself. It has grown revenue by at least 32% every year over the past decade. Even now as Alibaba grapples with the COVID-19 crisis and the country's common prosperity objectives, trailing revenue has climbed 40%.\n2. Zoom Video\nThe rise and fall of Zoom Video is well known. The videoconferencing platform skyrocketed in popularity during the early months of the pandemic when in-person classes, work meetings, and gatherings of friends and family weren't safe. Now that we're largely vaccinated and case counts are lower is there really a future for Zoom?\nThe market seems to think that the future will be bleak. Like Alibaba, shares of Zoom peaked 13 months ago. Zoom stock has plummeted 57% since that high. The twist here is that Zoom is still growing. Revenue rose 54% inits latest quarter. Sure, revenue is decelerating. We're not going to return to the triple-digit top-line growth that Zoom posted in each of the five previous quarterly reports.\nHowever, Zoom is still growing in the recovery climate. Video meetings will continue to be a cost-effective way to gather and get things done. Zoom is fleshing out its offerings, and a recently fumbled acquisition attempt won't stop the evolutionary process. There was a crazy time last year when Zoom was trading for more than 100 times trailing revenue. The one-two punch of heady sales growth and the cascading stock price finds that multiple whittled down to just 20 right now.\n3. Pinterest\nA year ago we were leaning on Pinterest to get crafty. The visual discovery engine was a valuable resource for recipes, decorating tips, and daydreaming about destinations we wanted to visit once we were able to safely travel after the pandemic.\nEverything was going swimmingly for Pinterest until we were cool to toss out our sourdough starter and head outside to eat someone else's bread. Pinterest has now stunned investors with back-to-back sequential declines in active users. The stock has plummeted 49% from February's peak.\nLast month PayPal Holdings was reportedly negotiating to buy Pinterest in a largely stock deal that would value Pinterest at$70 a share. Pinterest investors who were cocky about holding out for more would love a chance to get back there, as the stock has fallen sharply since the proposed combination came undone. Pinterest would have to appreciate by 53% to get to $70 now.\nPayPal stock sold off on the initial chatter, but it continues to fall even now that a deal is not on the table. It probably won't come back on bended knee now that both stocks are out of favor, but Pinterest still has a vibrant platform with improving monetization. Revenue is still growing as advertisers flock its marketing opportunities to reach the lucrative Pinterest audience.\nAlibaba, Zoom, and Pinterest are still thrivinggrowth stocks. The shares just happen to be trading between 49% and 57% off their all-time highs. You don't need to wait for the market crash to happen to pick up bargains. They're out there now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}